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Abstract
Medical diagnostics plays a critical role in human healthcare. Blood analysis is one of the
most common clinical diagnostic assays. Biomedical engineers have been developing
portable and inexpensive diagnostic tools that enable fast and accurate tests for individuals
who have limited resources in places that require such field applications. The emergence of
Lab-on-a-CD technology provides a compact centrifugal platform for high throughput blood
analysis in point-of-care (POC) diagnostics. The objective of this thesis work is to develop a
Lab-on-a-CD system for parallel quantitative detection of blood contents.

Blood separation is a key step in blood analysis. By integrating out-of-plane microvalves into
the Lab-on-a-CD system, pure plasma is separated from human whole blood sample for
subsequent blood detection. These out-of-plane microvalves show excellent performance in
preventing backflow or reverse mixing due to blood cell diffusion. The concentrations of
certain blood contents in the separated plasma can be detected using the electrochemical
biosensors embedded in the plasma reservoir. To improve sensitivity, a nanoporous structure
is created on the surfaces of the biosensors’ electrodes through an alloying/dealloying
process. The nanoporous electrode has an electroactive surface area up to 60 times larger
than that of a flat gold electrode of the same size. As a result, numerous catalysts and
enzymes are stably entrapped in the nanoporous structure, leading to high sensitivity,
stability and reproducibility of the biosensor.

Based on this devised blood separation technique and the improved electrochemical detection
method, a Lab-on-a-CD prototype was constructed and successfully applied in the
concentration detection of glucose, lactate and uric acid with linear ranges of 0 – 30 mM, 0 –
1.5 mM and 0 – 5 mM, respectively. Furthermore, the volume of whole blood sample
consumed for each section can be as small as 16 µL.

iii

The Lab-on-a-CD platform developed in this thesis is low-cost, robust, and simple-to-use.
Potentially, it could be used in clinical diagnostics and will especially aid developing
countries where resources are limited.

Keywords
Lab-on-a-CD, point-of-care, blood analyses, out-of-plane microvalves, electrochemical
detection.
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Chapter 1
1 Introduction
The background of this thesis work is briefly introduced in this chapter, followed by
the research objectives and outline of this thesis.

1.1 Background
Diagnostics plays a critical role in health care by providing a timely health care for
patients and high-risk groups as well. Approximately 740 tests are currently offered
by a central clinical laboratory [1]. 700 out of the 740 tests are used as diagnostic
tests and most of them are conducted on blood. The market for blood analysis is
valued at $50 billion across the globe: $17 billion goes to the manufacturers of in
vitro diagnostic equipment and supplies, and $33 billion is used for medical
technology/clinical chemistry staff and other associated service costs [2]. Obviously,
new technologies are needed to reduce the cost of blood analysis in order to make it
accessible for people all over the world.

Further, the time factor of diagnostic testing is important. The accuracy of the result is
higher if the test result is immediately obtained compared to the one obtained hours
later for the large majority of diagnostics [3]. For example, real time results for blood
glucose tests are often mandatory as the concentration of physiological chemicals
rapidly changes. That increases the weightiness of point-of-care analysis devices [46]. Currently, a number of high accuracy biotechnologies have been developed and
used (more details are available in Chapter 2). However, not all these technologies
could be transferred and affordable for people in developing countries. Meanwhile, a
formal lab environment is often not possible for health care workers in the field.
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Lab-on-a-CD [7] technology, a main branch of Lab-on-a-chip [8] technology, turns
out to be an ideal miniaturization for chemical/biochemical tests, which is realized by
the intrinsic pumping and separation mechanisms based on the centrifugal field on the
entire circular disc (CD) platform. The separation mechanism is ideal for blood
analysis because blood separation is the first step for whole blood analysis [9]. The
accuracy of whole blood analysis may be disturbed by the existence of blood cells.
These characteristics of Lab-on-a-CD technology inspire this thesis work in further
exploring an automatic, portable, point-of-care, cost-effective and fast system for
blood analyses.

1.2 Research Objectives and Outline of this Thesis
It is the aim of this thesis work to explore a portable and low-cost system for one-step
blood separation and analysis. To achieve this aim, a microfluidic cartridge for whole
blood separation and an innovative electrode system for electrochemical detection in
microfluidic channel were designed and studied. A Lab-on-a-CD prototype was built
to conduct multiple tests simultaneously.

Chapter 2 presents a review of the status of point-of-care (POC) diagnostics and the
major features of the Lab-on-a-CD platform. Meanwhile, comparisons are made
between the conventional blood analysis systems and other POC systems, leading to
the research objectives of this thesis.

Since blood separation of whole blood is the first step for clinical blood diagnosis,
Chapter 3 describes a novel design for an out-of-plane microvalve that enables high
performance of whole blood separation on Lab-on-a-CD centrifugal devices. The
principle of design and experimental details of device fabrication are presented.
Further, the control experiment without out-of-plane microvalves was conducted to
evaluate the performance of the microvalves.
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Chapter 4 focuses on design and optimization of prussian blue (PB) and multi-wall
carbon nanotubes (MWCNT) based electrodes for electrochemical biosensing of
analytes in the separated plasma. The factors that might affect the performance of the
biosensor were evaluated. It was found that the immobilization methods and the
amount of glucose oxidase (GOx) mainly influenced the sensitivity of the glucose
biosensor, while the amount of Nafion affected both the sensitivity and the linear
range of the glucose biosensor.

In Chapter 5, a nanoporous structure was created on the surfaces of electrodes through
an alloying/dealloying process. The creation of the nanoporous electrode is to
compensate the reduced surface area due to the miniaturization of the electrodes in
the Lab-on-a-CD system. Meanwhile, the electrode system embedded in the
microfluidic system may experience sample flow rates from nl s-1 to liter s-1 in the
centrifugal platform. Abundant catalysts and enzymes were stably entrapped in the
nanoporous structure, leading to high stability and reproducibility of the biosensor.

Chapter 6 demonstrates the performance of the completed Lab-on-a-CD prototype.
The prototype was assembled with a microfluidic cartridge for blood separation and
an electrochemical system for quantitative detection. Although only glucose, lactate
and uric acid were analyzed, the Lab-on-a-CD prototype is designed as a universal
platform to detect the concentration of analytes in whole blood only if hydrogen
peroxide is produced in enzymatic reactions.

This thesis ends with a summary of current research results and a prospective of
further research directions. Most of the work presented in this thesis has been
published in peer-reviewed journals or submitted for publication.

4

1.3 References
1.

Bailey, T., A practicum on making point-of-care testing work. American Clinical
Laboratory, 1997. 16: p. 10-11.

2.

MedPro Month, Diagnostic testing, outcomes and POC. Medical Data
International, January 1997. Vol. VII: No. 1.

3.

Kanji, S., Buffie, J., Hutton, B., Bunting, P., Singh, A., McDonald, K., Fergusson,
D., McIntyre, L. and Hebert, P., Reliability of point-of-care testing for glucose
measurement in critically ill adults. Critical Care Medicine, 2005. 33(12): p.
2778-2785..

4.

Ahn, C.H., Choi, J., Beaucage, G., Nevin, J.H., Lee, J., Puntambekar, A. and Lee,
J.Y., Disposable smart lab on a chip for point-of-care clinical diagnostics.
Proceedings of the IEEE, 2004. 92(1): p. 154-173.

5.

Tüdős, A.J., Besselink, G.A.J., and Schasfoort, R.B.M., Trends in miniaturized
total analysis systems for point-of-care testing in clinical chemistry. Lab on a
Chip, 2001. 1(2): p. 83-95.

6.

Yager, P., Domingo, G.J. and Gerdes, J., Point-of-care diagnostics for global
health. Annual Review of Biomedical Engineering, 2008. 10: p. 107-144.

7.

Madou, M., Zoval, J., Jia, G., Kido, H., Kim, J. and Kim, N., Lab on a CD.
Annual Review of Biomedical Engineering, 2006. 8: p. 601-628.

8.

Chin, C.D., Linder, V. and Sia, S.K., Lab-on-a-chip devices for global health: past
studies and future opportunities. Lab on a Chip, 2006. 7 (1): p. 41-57.

9.

Zhang, J., Guo, Q., Liu, M., snd Yang, J., A lab-on-CD prototype for high-speed
blood separation. Journal of Micromechanics and Microengineering, 2008, 18,
125025.

5

Chapter 2
2 Literature Review
In this chapter, the status of point-of-care (POC) diagnostics is reviewed. POC is
normally defined as any testing performed near the patient, and its essence is to
miniaturize and integrate diagnostic equipment onto a compact platform. The Lab-on-aCD technique provides such a compact platform, and its major features are introduced
here. Since this thesis focuses on how to transfer the blood analysis process from the
macro world into the micro/nano world, conventional blood analysis systems are
compared with other POC systems.

2.1 Point-of-care Diagnostics
Diagnostics have already made great contributions to health care in the developed world,
e.g. ensuring safe blood banking, providing appropriate and timely care to patients and
crucial surveillance data for both emergency public health interventions and long-term
public health strategies. Evaluating and improving patients’ medical conditions need
effective diagnostic tools. For the most part, new diagnostic systems developed by
biomedical engineers are in response to the needs of the medical community in only the
developed countries due to the new technologies’ necessity for highly regulated and
quality-weighed environments of centralized laboratories.

However, the majority of people afflicted with various kinds of diseases only have access
to poorly resourced health care facilities with almost no supporting clinical laboratory
infrastructure. For example, many developing countries do not own modern equipment
similar to those in central facilities in developed countries to perform up-to-date
diagnostics. Besides hardware, lack of training for operators, lack of standardization in
the evaluation of new diagnostics in relevant settings [1], lack of quality assurance [2, 3]
and insufficient advocacy to influence adoption rates [4] have all limited the access to
appropriate tests for patients. Therefore, approaches used in developed countries do not
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fulfill the needs of developing countries. A major task for the biomedical engineering
community is to develop POC tests, which allows the test to be brought conveniently and
immediately to the patient, meeting the needs of people from various living environment.

The knowledge of what actual constraints and requirements exist in developing countries
is important in developing appropriate POC diagnostics for low resource settings. The
laboratories in such environments face not only traditional constraints (e.g. low water
quality, insufficient power supply and inconsistent refrigeration quality) [5-7], but also
additional challenges, which are listed as follows:
1. Inequality of laboratory facilities and capacities within a country and among
countries.
2. Poor external quality control and laboratory management systems.
3. Lack of basic essential equipment and laboratory consumables.
4. Unreliable quality of reagents and unsecured supply chains.
5. Insufficiently skilled staff and limited training opportunities.

These factors result in POC diagnostic tests possessing low complexity, while keeping
the same level of diagnostic accuracy. The definition of complexity comprises of the
number of manual operation steps, the number of instruments involved, the level of
necessary training, and the need for user interpretation. The accuracy of the result is
characterized by the detection limit, the clinical sensitivity, and specificity. In addition,
practical POC testing should be low cost and have short turn-around time. Generic
guidelines developed by the World Health Organization (WHO) for the development of
POC devices used in the developing world can give more detailed information [8]:
1. Affordable by those at risk of infection.
2. Sensitive (few false positives).
3. Specific (few false negatives).
4. User-friendly (simple to perform and requiring minimal training).
5. Rapid (to enable treatment at first visit) and robust.
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6. Equipment-free.
7. Delivered to those who need it.

Apart from clinical needs and user requirements, the political regulation also has a strong
impact on the design of POC devices. For example, the US Food and Drug
Administration (FDA) defines POC diagnostics as “simple” and as having “insignificant
risk of an erroneous result”. The design specifications are as follows:
1. Fully automated instrument or unitized, using direct and unprocessed
specimens/capillary blood (finger stick), nasal swabs, or urine.
2. Needs only basic specimen and reagent manipulation.
3. Needs no operator calibration, interpretation and intervention during the analysis
steps, no technical or specialized training, no electronic or mechanical
maintenance.

Under these guidelines, POC diagnostic research has experienced many successes. In the
past decade, there has been a continuous growth in publications about early stage
technologies for overcoming the hurdles and barriers of introducing diagnostics into the
developing world. The conventional POC testing methods include agglutination tests, the
detection of the pathogen specific antigen or antibodies by lateral flow tests (rapid
diagnostic tests), and direct detection of the infectious agent by microscopy (Figure 2.1).
Ideally, these tests can provide helpful information. However, most biological data
cannot be extracted by these simple devices, and their robustness and accuracy are not
enough. Progress in science and technologies, such as genome sequencing and highthroughput antigen screening, have accelerated the research on disease pathogenesis at a
molecular level and the identification of biomarkers for pathogens and diseases.
Furthermore, the emergence of microfluidic technique [9-11] and nanotechnology
provide a compact platform to integrate sample processing, assay performance, analyte
detection, etc.
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Figure 2.1:Schematics of conventional POC testing procedures (a) An agglutination
diagnostic test. (b) A lateral-flow test such as for malaria antigen detection. (c) Light
microscopy using Giemsa stain for the detection of malaria. Figures adapted from
Ref [12-14].

Recently, our daily tools (cell phones, paper, and cameras) have been creatively involved
in the design of POC devices. For example, Stedtfeld et al reported an inexpensive, userfriendly and compact microfluidic device for rapid quantitative detection of multiple
genetic markers with high sensitivity and specificity. The device (Figure 2.2) was
operated using an iPod Touch, which was used to receive data and carry out automated
analysis[15]. Using paper as a platform, Nie et al [16, 17] reported detection of
metabolites through the combination of a commercial hand-held glucometer with easily
fabricated Micro-Paper-based Analytical Devices (Figure 2.3), and Yang et al [18]
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reported detection of glucose with an optical method. Breslauer et al [19] developed
camera-enabled mobile phones for the diagnosis and screening of hematologic and
infectious diseases (Figure 2.4).

Chip insertion door
Battery
indicator

Power
button

Figure 2.2: Picture of a cell phone based automated analysis system, which contains
an iPod docked on a recharge port and a disposable microfluidic chip sitting on the
door. Figure adapted from Ref [15].

Figure 2.3: Microfabricated paper-based analytical chips and their application in a
commercial hand-held glucometer. Figure adapted from [17].
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Filters and LED

Cell phone with built-in camera

Figure 2.4: Picture of a camera-enabled mobile phone with filters and LED installed
for the diagnosis and screening of hematologic and infectious diseases. Figure
adapted from Ref [19].

To sum up, miniaturization and integration of existing diagnostics steps into a
microfluidic system has been a prominent trend that provides low-cost yet simple
diagnostic methods without sacrificing test accuracy. The microfluidic technique solves
many issues by lowering test complexity and reducing cost, but the implementation of the
existing POC devices heavily depends on complex driving and regulating systems for
sample manipulation. For example, microfluidic pumps are widely used to provide
driving force [20-22] and compressed air supplied from external sources is employed to
offer the microvalve function [23-28]. Based on the microfluidics, nanotechnology and
biochemistry, the concept of Lab-on-a-chip [29-33] or Lab-on-a-CD [34] has been
established. This has led to the trend of developing accurate and sensitive diagnostic tests
for POC [11, 35-37], in both high-income countries and the developing world. Therefore,
more work is required to further simplify and miniaturize the POC devices.
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2.2 Lab-on-a-CD Technology
Lab-on-a-CD technology is a main branch of Lab-on-a-chip technology. With reservoirs,
chambers, connecting microchannels and vents built in, the compact disc (CD) platform
can be used to conduct various kinds of chemical and biochemical reactions (Figure 2.5).
Inertial forces (centrifugal force, Coriolis force, and Euler force) induced by rotating the
CD are utilized to manipulate the liquid’s movement from the rotating center to the
peripheral, and transport samples and reagents from the inlet reservoirs to the metering,
mixing, reaction, detection and waste reservoirs. Sampling processes, such as valving,
mixing, metering, sample splitting and separation, are implemented on the CD platform
with the combination of inertial forces and designed microfluidic structure. These are a
pre-analytical step of the platform, while the analytical step involves analytical
measurement using techniques, such as optical measurement and electrochemical
measurement. These two parts together make the centrifugal platform a powerful solution
for medical and clinical diagnostics. The underlying physical principles of microfluidic
manipulation are presented below.
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Figure 2.5: Schematics of a Lab-on-a-CD system.

2.2.1 Microfluidic Pumps
Actuation of microflow is a core function in a microfluidic system and several methods
of fluid propulsion have been developed to move small quantities of fluids or suspended
particles from reservoirs to mixing and reaction sites, to detectors, and eventually to
waste chambers. Methods to accomplish this include syringe and peristaltic pumps,
electrochemical bubble generation, acoustics, magnetics, electrokinetics, centrifuge,
etc.[38-42].
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Mechanical pumps [43] are based on well-developed, commercially available
components. The generated pressure is a volume-dependent force, which scales as L3 (L,
characteristic length corresponding to the capillary diameter), and a diverse range of flow
rates is available, from less than nL s-1 to L s-1. Electro-osmotic, electrowetting, and
electrohydrodynamic pumps [44-49] possess better performance in small and long
channels compared to mechanical pumping because they all scale as surface forces (L2).
No moving parts are needed, and the average flow rates for these pumps are from 1 nL s-1
to 1 µL s-1. By oscillating the sound field at the solid/fluid boundary, the acoustic pump
produces a constant fluid motion with a flow rate up to 20 µL s-1. The problem for this
type of micropump is that heat can be generated in sample fluids due to the dissipation of
acoustic energy. The centrifugal pump herein means the rotating circular platform. Its
flow rates depend on disc geometry, spinning speed, and fluid properties, ranging from
less than 10 nL s-1 to greater than 100 µL s-1. The advantages of centrifugal pumps are
revealed with its simple driving mechanism, which reduces the need for an external
pumping system, and its relative insensitivity to physicochemical properties, such as pH,
ionic strength, or chemical composition, which are important factors for AC and DC
electrokinetic means of pumping.

Four types of forces may be produced on a liquid plug on a rotating CD. The first one is
centrifugal force that commonly occurred in a rotating and non-inertial reference frame
and is defined as an outward force away from the rotational center (Figure 2.6). The
centrifugal force occurring at a liquid plug on a rotational platform can be defined as:

  
F  m  (  r )  mr 2

(2.1)

where m is the mass of the liquid plug, r is the distance from the center of the liquid plug
to the center of the platform, and ω is the rotating speed. The centrifugal force radially
points outward, and exerts a pressure difference upon each liquid segment, which can be
expressed by [50]:
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dP 

F
 r 2 dr
A

(2.2)

where dr is the length of the liquid segment. Integrating this pressure difference along the
whole length (R1 to R2) of the liquid plug, we can calculate the pumping pressure acting
on this liquid plug, which is given by Equation 2.3:

1
P   2 ( R22  R12 )
2

(2.3)

Since the pressure induced by centrifugal force is known, we can infer the flow rate in a
rectangular channel. It is assumed that it is a laminar and incompressible flow with a nonslip boundary condition (Poiseuille flow).The volumetric flow rate Q can be

PWH 3
Q
12L

(2.4)

Where ∆P is pressure drop and µ is dynamic viscosity. W, H and L are the channel’s
width, height, and length respectively. Substituting ∆P in Equation 2.3 to Equation 2.4,
the flow rate can be expressed as a function of rotating speed:

 2 ( R22  R21 )WH 3
Q
24L

(2.5)

In order to demonstrate the feasibility of this centrifugal platform, it is assumed that a
water plug located at R1 (20 mm) and R2 (30 mm). A pumping pressure of 6 kPa can be
generated with rotational speed of 1500 rpm. By properly controlling the rotational speed,
distance between the sample and the rotational center, geometry of the channel and
fluidic properties, we can make the liquid plug move in the channel at a specific flow rate.
Considering water flows in a channel with square cross (50 um), a flow rate of 0.12 μl/s
can be achieved.
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Figure 2.6: Schematic forces acting on a liquid plug on a rotating platform.

The movement of the sample in a rotational platform is affected by another factor, called
the Coriolis effect, which is the behavior added by the Coriolis acceleration. The Coriolis
acceleration is perpendicular both to the direction of the velocity of the moving mass and
to the frame's rotation axis, and the magnitude of the Coriolis acceleration is proportional
to the velocity of the object. The induced Coriolis force can be expressed as:

F  2m  V

(2.6)

Where m is the mass of the sample in the rotating system,  is the angular velocity
vector (perpendicular to the plane of CD) and V is the velocity of the object in the
rotating CD platform. Therefore, the Coriolis force commonly occurs in the rotating CD
and acts in a direction perpendicular to the velocity of the sample. This force can work
with centrifugal force together to change the flow path of fluid samples (Figure 2.7). The
typical applications of the Coriolis effect are shown in enhancing mixing for laminar flow
in microfluidic channels [51], controlling flow direction at a bifurcation [52], etc.
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Figure 2.7: Flow switching in a symmetric, inverse Y-structure. (a) At low
frequencies ω, where the Coriolis force is negligible, the flow evenly flows through
both outlets. (b) At frequencies beyond ω0, a larger Coriolis force can guide up to
100% of the flow into one outlet according to the direction of rotation. Figure
adapted from Ref [53].

Furthermore, if the angular frequency of a rotating CD varies, a third force, called Euler
force, will be generated as a function of the angular acceleration. Based on Newton’s
second law of motion, Euler force FE acting on the fluid elements can be derived
from  m

d
 r , where r is the radial distance of the accelerating point from the center of
dt

rotation. The Euler force has been reported to help mixing samples as well (Figure 2.8).
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Figure 2.8: Changes of rotation lead to an Euler force (FE) on the bead and the
liquid. Advective currents due to the FE can speed up mixing. Figure adapted from
Ref [54].

Another dominant force acting on microfluidic platforms is capillary force. It is different
from the previous forces because it does not rely on the rotation of the CD platform.
Capillary force exists in any microfluidic channel, and can be either a driving force or a
resisting force, depending on the surface tension of the fluid and the surface energy of the
channel surface. Surface tension, caused by the inter-molecular attractive forces of the
liquid, is the force that holds a liquid together. Take the interface between water and air,
for example. All the water molecules close to the surface are pulled inwards, forming a
spherical droplet. This tensile force divided by the length of the contact line on the
interface (N/m) is defined as surface tension (  ).

Surface energy is used to quantify the breakdown of intermolecular bonds on a freshly
created surface. The surface energy is quantified with the forces acting on a unit length
at the solid-air or the solid-liquid interface, sharing the same unit as the surface tension.

18

When liquids are in contact with solids, the formation of droplets or thin films depends
on the force balance of surface tension and surface energy.

Affinity of a flat surface towards a certain liquid is defined in terms of the “flat” (or

intrinsic, or Young’s) contact angle,
cos( flat ) 

 SA   SL
 LA

(2.7)

where γrepresents the surface energies (or surface tensions), subscript S stands for solid,

L – for liquid, A - for air The solid-liquid surface energy can be approximately estimated
via the other two as follows [55]:

 SL   SA   LA  2  SA LA

(2.8)

The surface is called (hydro-, oleo-, etc.)-phobic if   90  , and -philic if otherwise.

Due to the surface tension, a pressure gradient exists across the interface. Assuming a
droplet forms a curve interface in a cylindrical channel (radius: R), the pressure
difference across the interface can be deduced from the following force balance:

 cos( )(2R)  ( Pi  Pj )R 2

(2.9)

where Pi and Pj are pressures on both sides of the interface. As P  2 cos( ) / R , the
capillary action makes a great contribution to the force balance on a microscale channel.

2.2.2 Microfluidic Valves
Microfluidic pumps provide driving force for the microfluidic network, but the precise
manipulation of the fluidic movement requires the participation of microfluidic valves. In
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a multi-step assay, sample fluid flows through different sites in sequence. For example,
the sample needs to remain at specific places for processing and is then released to the
next chambers. Based on the differences of actuating mechanisms, microfluidic valves
can be divided into passive valves and active valves. Passive valves involve the control of
geometries and material properties of channels as well as the rotational speed, while
active valves employ external excitation to control the opening or closing of the valves.

As shown in Equation 2.9, pressure drops across a microfluidic channel are related to the
size and wettability of the channel. If the channel is hydrophobic, the fluid flow will
experience resistance. By abruptly narrowing down a section of the hydrophobic channel,
thus reducing R, we can apply much stronger resistance to the fluid flow. Alternatively, if
a channel is hydrophilic, a driving force will be exerted on the fluid flow. By placing a
hydrophobic patch (changing θ) in the hydrophilic channel, we can switch the driving
force to a resisting force [56]. Therefore, the narrow section and the hydrophobic patch
can both serve as passive microfluidic valves, categorized as hydrophobic valves (Figure
2.9 A, B). Further, if a channel is completely hydrophilic, the fluid flow can be retained
by abruptly expanding the cross section of the microchannel (enlarging R), resulting in a
smaller pressure drop. This abrupt expansion of the microchannel is used as a capillary
valve, which is also a kind of passive valves (Figure 2.9 C). Operations of the
hydrophobic valves and capillary valves are determined by balancing the centrifugal
force due to rotation and the resisting force due to surface properties and geometry of the
valve. The liquid meniscus is stopped at the valve area until the pressure induced by
centrifugal force overcomes the one induced by the microfluidic valve. These
microfluidic valves can be easily adapted to CD platforms and do not require external
actuation forces. However, these valves are not compatible with low surface tension
liquids as they have small contact angles and readily wet polymer surfaces, rendering the
valve structures useless [57].
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Inspired by the siphon effect, a hydrophilic channel, like Figure 2.9 D, can serve as a
microfluidic valve, called a siphon valve [58-60]. The siphon valves are inverted Ushaped channels bent at a crest point located radially farther inward with hydrophilic
inner surfaces, fluidically connecting two chambers. The outflow chamber has a higher
relative energy potential than the inflow chamber within a centrifugal acceleration field.
At a high angular frequency ωc, the centrifugal force Fc prevails over the capillary force
Fθ in the inbound section, localizing the liquid in the first chamber at a level below the
crest of the siphon. When the angular frequency is reduced or the rotation ceases, liquid
spontaneously primes the siphon by capillary action. Maintaining this capillary priming
until the advancing meniscus has passed the crest point of the siphon and settles below
the position of the receding meniscus in the first chamber. Now a low angular frequency
is sufficient to drive the fluid and finally connect these two chambers. Once these two
chambers are connected, the movement of fluid will not cease until air is sucked into the
inbound channel. These valves depend exclusively on the surface properties of the
channels and require precise control of rotation, so their usages are limited.
A

B

Hydrophobic
patch
Rotational center

|ω| > ωc
C

|ω| > ωc
D

Plug

|ω| > ωc

|ω| < ωc

Figure 2.9: Principal centrifugal approach and schematic sketch of the three valving
techniques on the centrifugal platform. (A, B) Hydrophobic valves (C) Geometric
capillary valve (D) Siphon valve. By adjusting the rotational speed ω, we can control
the open or closed status of these microfluidic valves.

21

Among many active microvalves used in microfluidic applications, optofluidic valves,
opened by directing optical energy from a solid-state laser, are particularly attractive for
disposable biochip applications because they are simple to implement, cost-effective and
biocompatible. Park et al reported phase change based microvalves using paraffin wax
mixed with nanoheaters (Figure 2.10) [61], and Garcia-Cordero et al used a laser to
localize heating to melt an orifice in the polymer layer, connecting previously isolated
fluidic components or compartments (Figure 2.11) [62]. The disadvantage of this kind of
valve is that they are only for single use. Researchers are still trying to develop more
robust active microfluidic valves. For example, Markov et al [63] fabricated a tape
underlayment rotary-node microvalve (Figure 2.12), and Park et al [64] created a
membrane-type microvalve in rectangular microfluidic channels through seal
photopolymerization (Figure 2.13).

(a)

(b)

Figure 2.10: Schematic of laser controlled microvalves using paraffin wax. (a) To
open the normally closed valve, the laser beam is focused at the valve location and
the molten ferrowax flows to the assistant valve chamber, opening the valve. (b) To
close the normally opened valve, the laser beam is focused at the pre-loaded
ferrowax chamber located adjacent to the main channel and the molten ferrowax
bursts into the main microchannel, closing the channel. Figure adapted from Ref
[61].
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Figure 2.11: Schematic of laser melted microvalves. A main channel is separated
from a connecting channel by a piece of polymer foil (valve closed). A laser beam is
used to melt orifices between the main channel and the connecting channel (valve
opened). Figure adapted from Ref [62].
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Figure 2.12: A schematic representation of a tape underlayment rotary-node valve
and its working principle.
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Figure 2.13: A schematic representation of a polymer-sealed microvalve and its
working principle. Figures adapted from Ref [63, 64].
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2.3 Blood Analysis
Blood analysis is the most commonly-used diagnostic method nowadays due to the
definitive information of patients’ medical conditions provided by blood tests.

2.3.1 Conventional Blood Analysis Methods
Traditional blood analysis includes sample collection, preparation and detection. These
three processes are commonly conducted in diverse locations and at different time
periods. Blood samples are taken from patients by nurses at hospitals or clinics. Five to
ten mL of whole blood is stored in labeled tubes (Figure 2.14 a). These tubes are then
collected and sent to central laboratories for further processing by specific laboratory
technicians. Plasma is separated from blood cells by centrifuging the tubes, effectively
trapping the blood cells in the sediment and lifting the plasma up to the supernatant
(Figure 2.14 b). The plasma is extracted for subsequent quantitative detections. These
detections can be conducted using colorimetric analysis methods and electrochemical
analysis methods. Large scale spectrometers are employed in the colorimetric
measurements and standard electrochemical working stations are utilized in the
electrochemical detections (Figure 2.14 c, d). This blood analysis regime has been
successfully applied to provide accurate results for physicians in the diagnosis of
symptomatic patients or in the preventative program.

Since numerous personnel and process steps are involved in the blood test, the possibility
of quality failure is increased. The entire blood test can be categorized into two processes:
Process I, which occurs in the patient-care department, such as test requisition (nurse),
sample acquisition (nurse or phlebotomist), labeling (nurse or phlebotomist),
transportation (transporter), and receipt of results (nurse); and Process II, which takes
place in the laboratory, such as sample receipt and aliquoting (clerk), and centrifuging,
analysis, and results reporting (medical technologist). Any mistake that occurs during this
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process, e.g. mislabeled samples or deteriorated samples during transportation, would
lead to failure of testing.

People have to pay attention to the method of recognizing the test results, although there
is no mistake involved in the process flow. Normally, it takes a few days after taking
blood samples from the patient to release the test result to the patient. Unfortunately, the
processing time would readily be doubled if the result is doubted and the request to remeasure the blood is made. Considering the issue described above, the patient will feel
more confident in the blood result if the procedures for labeling and transporting blood
samples are eliminated and the measurement can be performed with a customer-friendly
analysis device at the patients’ side.

The completed cost of the blood test comes from the sample acquisition and
transportation, analytical equipment, reagents and the associated labor cost. Cost savings
can be achieved by switching the multistep laboratory process to a one-step patient-side
alternative. For example, blood sampling is performed by pricking the finger into
receptacle instead of by a nurse. Sample storage, transportation and processes in the
patient-care department and laboratory would be eliminated so long as the patient-side
device is designed appropriately.

The turn-around time for diagnostic testing is very significant. The high accuracy of
results is ensured only when the test result is provided instantaneously, which is hardly
realizable by the majority of diagnostics conducted in the central lab. For example, real
time results for blood glucose tests are often mandatory as the concentration of
physiological chemicals rapidly change. The timely manner further increases the
importance of POC analysis devices. Nowadays, a number of high accuracy
biotechnologies have been developed and used. However, not all these technologies
could be transferred and are affordable for those people with low-resources in developing
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countries. Moreover, a formal lab environment and experienced professionals are often
not accessible in the field. Developing simpler, more robotic and affordable devices
becomes necessary.

(a)

(b)

(c)

(d)

Figure 2.14: (a) Sample taking (b) Sample processing (c) Spectrometer used to
conduct optical measurement (Beckman 64, UV/Vis) (d) Blood glucose meter for
electrochemical measurement (Yellow Springs Instruments 23A). Figures adapted
from www.labx.com.

2.3.2 Point-of-care Blood Analysis Systems
Point-of-care blood analysis systems are aimed at accomplishing blood tests in a simple
and robust way, and deliver laboratory accuracy and reliability in patient-side locations
which are far less well controlled than the laboratory. The commercialized techniques of
POC blood analyses can be sorted into two major groups: electrochemical detection with
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whole blood sample, which is represented by i-STAT from Abbott; and colorimetric
measurement on plasma extracted from whole blood, which is demonstrated by Piccolo
xpress of Abaxis.

The electrochemical method (U.S. Patent 5,200,051) i-STAT employed to analyze whole
blood is fast and convenient. The system is composed of three parts: a plastic cartridge as
a sample receptacle, a microfabricated biosensor array installed in the plastic housing,
and a low-cost general-purpose electromechanical transducer. The cartridge is a total
microanalytical system with a sandwich structure formed by bonding a lower plastic
component and upper plastic component. In the cartridge, all the necessary fluidics
function units, such as chambers, pumps, valves, conduits, mixers, and separators, are
built in, and reagents, diluents and biosensor arrays are pre-loaded. The fluid sample
inside the cartridge is driven by capillary force and pneumatic pressure, while the
cartridge itself does not move. The existence of blood cells, however, leads to an error of
10% - 15%.
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Figure 2.15: Portable blood analyzer from I-STAT and the exploded view of its
cartridge. Figure adapted from Ref [65].

Piccolo xpress (U.S. Patent 5,122,284) consists of a single-use reagent rotor and an
optical analyser. The system uses capillary force and centrifugal force as driving forces to
complete all sample processing and optical analysis. The reagent rotor with a diameter of
80 mm consists of three functional layers, where all the dry reagents and the diluents
were preloaded. The bottom and middle layers are bonded to form a fluidic system that is
composed of cuvettes, chambers and fluidic channels for the manipulation of the sample
fluid. In this microfluidic layer, plasma is separated from whole blood samples and
guided to the cuvettes, where lyophilized reagent beads are placed for chemical reactions.
The top layer provides imprinted bar-coded, rotor-specific calibration information to the
analyser. A sealed container is arranged in the center of the rotor, containing 475 µl of
diluents. The coefficient of variation (CV) of measurement results is from 0.07% to
0.47%. Unfortunately, the size of its chip is not within the micron scale, thus the amount
of consumed blood for detection is relatively large. Meanwhile, optical devices for
colorimetric sensing make the system heavy and expensive (more than $10,000).
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Figure 2.16: A compact blood analyzer from Abaxis and the exploded view of its
cartridge. Figure adapted from Ref [66].

In this research field, cost-effective microfluidic paper-based analytical devices (µPADs)
have emerged as a promising POC blood analysis technique. Paper possesses a few
advantages: extremely low-cost, porous and flexible. Whitesides’s group first
demonstrated how to fabricate a microfluidic network on paper and conduct optical or
electrochemical detections. For example, Vella at al reported that enzymatic markers of
liver function can be measured using a micropatterned paper device and blood from a
fingerstick (Figure 2.17) [67]. Since then, a large number of scientific reports from
various groups have claimed innovative developments in point-of-care devices made
from paper [68-79].
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Figure 2.17: Schematic of blood test on µPAD. A circular filter membrane catches
the red blood cells from a drop of blood. The membrane below contains three
microfluidic chambers that can measure the liver enzymes alkaline phosphatase
(ALP) and aspartate aminotransferase (AST) as well as serum protein. Colors
indicate levels of the enzymes and serum protein, and can be digitized by a cell
phone or desktop scanner for further analysis. Figure adapted from Ref [67].

Due to their huge potential market value, point-of-care techniques are rapidly progressing.
Various research groups [29, 80-88] and diverse pharmaceutical companies (Abbott,
Bayer, GE, Sumsung, Covidien, Pelican, Gyros, etc) heavily invest in every technique
that is possibly helpful for fabricating point-of-care devices. Meanwhile, in pursuit of
better diagnostic methods for people in developing countries and low resource areas, the
Bill & Melinda Gates Foundation has started the new push for research into POC
diagnostic devices [89].
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2.4 Summary
Current needs for accurate and low-cost diagnostic methods for global health are critical.
Significant advances in the newly developed diagnostic systems have provided
quantitative, novel diagnostic techniques with an analytical performance close to those of
conventional laboratory tests. However, further simplification of the testing procedures
and analyzers is still desirable, and strong efforts are directed towards the development of
miniaturized and simple, yet sensitive and quantitative detection technologies to meet the
need of POC diagnostics. A major challenge for biomedical engineers in the next few
decades will be how to translate recent technologies accomplishments into technologies
that are available and affordable at the periphery of the health care system. Of the new
techniques, perhaps the most promising at the moment is microfluidics, as it has the
potential to add capabilities for sample processing and complex fluidic handling while
being compatible with inexpensive materials and fabrication methods. A tiny droplet of
blood is enough for multiple blood tests on the microsystem, which dramatically reduces
the consumption of blood sample and reagents. The Lab-on-a-CD technique used in this
project acts as a special microfluidic platform, integrating sample processing and
analytical steps into one continuous process. In the next three chapters, a low-cost,
portable Lab-on-a-CD system for multiple and parallel point-of-care blood analyses will
be elucidated in detail.
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Chapter 3
3 Out-of-plane Microvalves for Whole Blood Separation on
Lab-on-a-CD
It has been mentioned in the previous chapter that the emergence of Lab-on-a-CD
technology provides a centrifugal and compact platform for high throughput blood
analysis in point-of-care (POC) diagnostics, and blood separation of the whole blood is
the first step for clinical blood diagnosis. This chapter describes a novel design of an outof-plane microvalve that enables high performance of the whole blood separation on Labon-a-CD centrifugal devices. The principle of design and experimental details of device
fabrication are presented. Further, the control experiment without out-of-plane
microvalve was conducted to evaluate the performance of the microvalve.

3.1 Introduction
Blood tests are the most commonly-used diagnostic methods nowadays because blood
analysis provides definitive information of patients’ medical conditions [1]. Traditional
blood tests, including sample collection, preparation and detection, are conducted using
large-scale blood analyzers. The advent of Lab-on-a-chip technology that takes advantage
of low volumes of consumed samples, fast response time and low fabrication costs in
mass production [2], makes it possible to integrate the whole procedure of blood analysis
into miniaturized devices.

Implementing blood separation, one of the key steps of blood analysis, on Lab-on-a-chip
devices has long been a major research focus. Crowley et al. employed transverse-flow
microfilter devices [3]. Arifin et al. spun blood cells down towards a bottom stagnation
point [4]. Yang et al. proposed a T-channel network structure [5]. Blattert et al. used a
bended microchannel structure [6] (Figure 3.1).
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Figure 3.1 (a) Transverse-flow microfilter devices (b) Spun blood cells down
towards a bottom stagnation point (c) A T-channel network structure (d) A bended
microchannel structure. Figures adapted from Ref [3-6].

The emergence of Lab-on-a-CD technology boosts the development of on-chip blood
separation. When rotating, Lab-on-a-CD devices not only act as centrifugal platforms for
fluid propulsion, but also provide inherent inertial forces for blood separation. Various
blood components of different mass densities will bear diverse body forces under specific
physical fields [7]. Haeberle et al. proposed a decanting structure to extract plasma from
the whole blood [8]. Recent studies carried out in our laboratory showed that a specially
designed curved microchannel network, taking advantage of two centrifugal forces and

45

Coriolis force due to the system rotation, was capable of separating diluted blood and
guiding blood cells and plasma to different reservoirs for subsequent analysis [9]. All of
these previous studies have raised more technical challenges that need to be solved, such
as, how to improve efficiency of blood separation (or purity of the separated plasma) for
the whole blood of high hematocrit; how to improve the plasma yield for subsequent
blood analysis; how to improve the readiness of plasma extraction; and how to reduce the
complexity of the device to increase reliability. For example, we have found that
prevention of blood cells diffusing from the sedimentation back to the supernatant can
effectively improve efficiency of blood separation, plasma yield and the readiness of
plasma extraction.

Ideally blood cells and plasma are better spatially isolated after separation for subsequent
plasma extraction and testing. This is also the main concept of our previous work [9]
delivering plasma and blood cells into two separate reservoirs. However, our previous
Lab-on-a-CD design worked well for diluted blood of 6% hematocrit, but not for the
whole blood of much higher hematocrit. The idea of the present work is to introduce a
newly designed microvalve, namely the out-of-plane microvalve, into Lab-on-a-CD
devices to spatially isolate plasma from blood cells after blood separation. Indeed,
various types of microvalves have been implemented in Lab-on-a-CD devices for
different purposes. Park et al. presented a phase change-based microvalve controlled by
laser illumination [10]. Madou et al. presented a polymer-based CD platform that utilized
capillary microvalve [11]. Steigert et al. brought forward the frequency-dependent
microvalve adopting the siphon effect [12]. Mark et al. proposed a novel design of
centrifuge-pneumatic valve which does not require ultra-precise structures or local
surface modifications [13]. there is continuing demand for microfluidic devices to
become lower-cost, easier-to-manufacture and easier-to-use for point-of-care (POC)
diagnostics [14]. Whitesides’s group developed a simple blood separation device
comprising only an egg beater and a piece of polyethylene tubing [15] (Figure 3.2).
Therefore our motivation is to integrate microvalves into a Lab-on-a-CD device to form a
structurally-simple but functionally-robust device, which is capable of high-performance
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blood separation and suitable for simple microfabrication methods like hot-embossing or
micro-injection molding.

The essence of the work presented here is the novel design of a simple but effective Labon-a-CD device with the three-dimensional out-of-plane microvalves for highperformance whole blood separation. The “close” or “open” status of the out-of-plane
microvalve is controlled by the rotational speed that determines the balance of centrifugal
force, hydrostatic force and capillary force related to the out-of-plane microvalve. When
the Lab-on-a-CD device spins above a certain speed, blood sample flows over the
mivrovalve, and sedimentation can be achieved on the rotating platform due to the
centrifugal force developed along the radial axis [16]. The accumulated blood cells are
confined in the downstream sedimentation reservoir by the microvalve, away from the
plasma in the upstream supernatant reservoir. The use of the out-of-plane microvalve
helps improve the efficiency of whole blood separation and the plasma yield. The
integration of the out-of-plane microvalve(s) into Lab-on-a-CD platforms is a simple,
easy-to-make and low-cost solution for blood separation. In next sections, the working
mechanism, device fabrication, experiments and blood separation results will be
introduced.
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Figure 3.2: A simple device composed of only an egg beater and a piece of
polyethylene tubing for blood separation. Figure adapted from Ref [15].

3.2 The Working Mechanisms
The phrase “out-of-plane” literally specifies a rise from the bottom of a microchannel. As
shown in Figure 3.3, the out-of-plane microvalve is designed as an upstanding block from
the bottom of the channel to a predetermined height inside the channel, leaving a
narrowed microchannel. The liquid level is horizontal when the platform remains still.
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But it begins to tilt when the CD platform starts to rotate. When the rotational speed is
below a threshold value, the microvalve is in “close” state. If the rotational speed is
increased above a threshold value, the liquid sample is able to flow over the microvalve.
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Figure 3.3: Schematics of the working mechanism of the out-of-plane microvalve on
a Lab-on-a-CD platform. The liquid level is horizontal when the platform is
motionless (ω = 0). The liquid surface begins to tilt under a rotational speed ω0
which is smaller than the threshold rotational speed. Under these two situations, the
microvalve is in “close” state and blocks the passage of fluid. If the rotation speed is
increased above the threshold rotational speed ω1, the microvalve is opened and the
liquid sample can flow over it.

Once the platform is stopped, no forces are available for the sample flowing backward,
and the microvalve blocks the passage of fluid. In this case, the out-of-plane microvalve
functions as a dam stopping the sample flowing backward. This is the core function of the
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out-of-plane microvalve designed to improve blood separation. To estimate the threshold
rotational speed ω1, we apply the principle of virtual work on the whole volume of liquid
for the moment that the liquid is going to flow over the microvalve.

The forces induced by the centrifugal platform at the out-of-plane microvalve are
simplified into three main categories. The first one is centrifugal force (Fc) which is the
driving force induced by the centrifugal platform. The other two are hydrostatic force (Fh)
and capillary force (fc) which are obstructive forces. When the sample flow primes the
microvalve, the capillary force at the narrowed microchannel above the out-of-plane
microvalve actually dominates the obstructive forces. To apply the principle of virtual
work, we assume a small amount of liquid ( As ) enters the narrowed microchannel by a
virtual displacement s , where A is the cross-sectional area of the narrowed
microchannel. In this case, the centrifugal force is the driving force doing positive work,
while the liquid needs to overcome the gravitational force and the capillary force when
the channel cross-section varies from wider to narrower, both of which are doing negative
work. According to the principle of virtual work, the total virtual work is zero:

WF  W g  W f c  0

(3.1)

where W F , Wg and W fc are the work of the centrifugal force, the gravitational force and
the capillary force, respectively, which are expressed as
L

WF   F ( x)  L( x)  dx

(3.2)

Wg   As  g (h / 2  H )

(3.3)

0

W fc  f c  s

(3.4)

In Equations 3.2-3.4, F(x), L(x) and fc are expressed as:

F ( x)  S ( x)  2 x

(3.5)
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L( x ) 
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S ( x)

(3.6)
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 1 1
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 b h

(3.7)

In above Equations, S(x) is the cross-sectional area of the sample liquid in the reservoir at
the location x, g is the gravitational acceleration, ρ is the sample density, ω is the
rotational speed, σ is the surface tension,  is the contact angle of sample on the channel
wall, H is the height of the microvalve and L is the length of the upstream reservoir. b
and h are the width and height of the narrowed microchannel above the microvalve,
respectively, and b and h are the width and height in the reservoir near the microvalve,
respectively.

From Equations 3.1 to 3.7, we can determine the threshold rotational speed, or so-called
the burst frequency [11], as follows:

 1
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(3.8)

1 1 
 1 1
The term " 4 cos (  )  (  ) " due to the capillary force is three orders of
b h 
 b h
magnitude larger than the term "  g (h  2 H ) " due to the gravitational force in Equation
3.8. Since the gravitational force has negligible effect in Equation 3.8, for simplicity.
Equation 3.8 of the burst frequency can be derived by Equation 3.9.

1 1 
 1 1
 4 cos (  )  (  )
b h 
 b h
1 
2
L

(3.9)
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The analysis above provides us guidance to control the “open” or “close” state of the outof-plane valve by adjusting the rotational speed. Using the following parameters, blood
surface tension (20 °C) σ = 0.052 N/m [17], density of blood ρ = 1060 kg/m3 [18], g = 9.8
m/s2, L = 0.02 m, h = 1×10-5 m, h = 5.5×10-5 m, b = b =2×10-3 m, H = 4.5×10-5 m, the

 1 is in the range between 797 rpm to 1352 rpm when  varying from 100° to 120°. In
numerous experiments we have done, the experimentally observed threshold rotational
speed ω1 falls in the range predicted by Equation 3.9, round 1100 rpm.

3.3 Experimental Design and Method
In this section, we present how the out-of-plane microvalve(s) is built into a centrifugal
platform to form a Lab-on-a-CD device for whole blood separation.

3.3.1 Materials
High-resolution (2000DPI) photomask printing service was provided by CAD/Art
Services Inc. Polydimethysiloxane (PDMS) replicate was prepared by mixing prepolymer
and curing agent (Sylgard 184, Dow Corning, Midland, MI) at a ratio of 10:1. Human
raw blood was drawn from a healthy donor at the University Hospital and stored in a
vacutainer containing anticoagulant (EDTA) at 4ºC. The stepper motor (RDK-STEPPER)
used to provide centrifugal force was purchased from Luminary Micro. Standard
materials for photolithography were available in Western Nanofabrication Lab at
University of Western Ontario.

3.3.2 Device Fabrication
A Lab-on-a-CD device may comprise a number of identical sectors for parallel blood
separation, each of which contains three main parts: a supernatant reservoir (~9.4 μL), a
sedimentation reservoir (~4.7 μL) and a connection section within which an out-of-plane
microvalve (radial width 250 μm) was built. The total height of the channel network
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structure is 55 μm, while the microvalve is 45 μm high leaving a 10 μm narrowed
microchannel to allow blood to pass through. The formation of the out-of-plane
microvalve involves 3D microfabrication processes. In this work, we develop an
innovative technique of fabricating 3D mold masters that are negative-photoresist (SU-8)
reliefs comprising multiple layers of photoresist overlaid on top of each other. The
fabrication process we proposed involves two major steps:
(1) Fabrication of the 3D photoresist mold with layers of photoresist (Figure 3.4(a)).
(2) Configuration of the microchannel network structure by casting PDMS on the
mold (Figure 3.4(b)).

a

b

Figure 3.4: Schematics of (a) The aligned bilayer photoresist mold for the out-ofplane microvalve and (b) A PDMS replicate fabricated out of the mold.

The photoresist mold in the first step was prepared by standard photolithographic
techniques [19]. To obtain maximum process reliability, silicon (Si) wafers were
thoroughly cleaned and dried before use. The bottom layer of photoresist (SU-8 3005,
Microchem, USA) was spun at 500 rpm for 5 seconds followed by 1000 rpm for 30
seconds on a Si wafer using a spin coater (Solitec 5110 Spinner) to obtain a thickness
of 10 μm (Figure 3.5(a)). This layer was exposed to ultraviolet (UV) light through the
first photomask using a mask aligner (Karl Suss MA6 Mask Aligner, sensor
wavelength = 405 nm), but not developed yet in this step (Figure 3.5(b)). After post
exposure bake, the wafer was spin-coated with another layer of photoresist (SU-8

53

Transparent photomask
(a) Spin the first photoresist layer

(b) UV exposure with the first photomask
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Figure 3.5: Detailed microfabrication procedures and dimensions for the Lab-on-aCD device with an out-of-plane microvalve. (a) Spin the first layer of photoresist, (b)
UV exposure with the first photomask, (c) Spin the second layer of photoresist, (d)
UV exposure with the second photomask, (e) Develop and cast PDMS, (f) Peel off
and bond with a glass wafer.

3025, thickness 45 μm) (Figure 3.5(c)). The second photomask with similar pattern to
the first one, but an opening in the area where the microvalve located, was aligned
with the bottom layer, followed by UV exposure (Figure 3.5(d)). After post exposure
bake, both photoresist layers were developed using SU-8 developer. Finally, the wafer
was rinsed with isopropanol (IPA) followed by deionized (DI) water and baked at 150
°C for 2 minutes, forming a positive and 3D insert mold on a wafer. The steps for
fabricating SU-8 structure on Si substrate using photolithography technique are also
shown in Figure 3.6.
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Figure 3.6: Graphic illustration of photolithography process for the fabrication of
molds.

In the next step, standard soft lithographic technique was employed to fabricate the
Lab-on-a-CD device [20]. 55 g (per master mold) of premixed PDMS was mixed and
poured into the SU-8 master mold in a Petri dish and degassed in a vacuum chamber
for a minimum of 30 min. After removing all the trapped air, the Petri dish was put on
a hotplate (65 °C for 3 h and 80 °C for 2 h) to cure the PDMS (Figure 3.5(e)).

The cured PDMS layer (~5 mm thick) was peeled off from the mold and bonded to a
Pyrex glass wafer (Figure 3.5(f))). Holes were drilled using round-headed diamond
drill bits (Brasseler, USA) on the glass wafer, serving as inlets and vents for the
patterned PDMS layer. Before bonding, the PDMS replica and the glass wafer were
cleaned with oxygen plasma (100 mW, 2% oxygen, 1 min) in a PX-250 plasma
chamber (March Instruments, Concord, MA) and then immediately placed in contact
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followed by baking at 70 °C for 1 hour to enhance the strength of bonding. Another
glass wafer was brought into contact with the other side of the PDMS replica as a
support layer. The steps for fabricating PDMS devices using softlithography
technique are also shown in Figure 3.7. A completed Lab-on-a-CD device is shown in
Figure 3.8(b).

As seen in the detailed fabrication steps in Figure 3.4, the height of the out-of-plane
microvalve is controlled by the thickness of the second photoresist layer, while the
size of the narrowed microchannel above the microvalve is determined by the
thickness of the first photoresist layer.

Mixed the base and curing agent
of PDMS in the mass ratio of 10:1

Pour PDMS prepolymer over
the patterned SU-8 mold

Degas the prepolymer soultion
in a vacuum desiccator

Peel off the PDMS layer
from the SU-8 mold

Place on a hot plate at 80 °C
for 2 hrs to cure the PDMS

Puncher

Fluidic port punching

Figure 3.7: Graphic illustration of softlithography process for the fabrication of
PDMS microfluidic structures.
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Figure 3.8: Characteristics of the Lab-on-a-CD device. (a) The full view of the Labon-a-CD system including a motor, a control board and the Lab-on-a-CD device. (b)
The sandwich structure of the Lab-on-a-CD device. The top layer is a glass wafer
with sample inlets and vents. The PDMS layer comprises 4 sections of identical
microstructure including a blood inlet, a supernatant reservoir, a sedimentation
reservoir, an out-of-plane microvalve and two air vents. Another smooth glass wafer
is used as a support layer. (c) Profiles of the out-of-plane microvalve in the mold and
in PDMS casting scanned by a surface profilometer. The profiles of the PDMS
casting and the inverted mold are compared. (d) SEM (scanning electron
microscope) image taken at the out-of-plane microvalve. A protrusion shown in the
microchannel is the out-of-plane microvalve.
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3.3.3 Blood Separation Experiments
9.4 μl of human whole blood was loaded into the upstream reservoir through each inlet
port (Figure 3.9(a)). Then the Lab-on-a-CD device was rotated at a set of predetermined
speeds which are above the burst frequency calculated using Equation 3.9 to exert
different centrifugal forces on the whole blood sample at room temperature.

To investigate the efficiency of blood separation, two sets of experiments were conducted.
The first set of experiments varied the rotational speed over a predetermined range (1500
rpm ~ 3000 rpm) while the rotational time was held constant. The second set of tests
adjusted the rotational time over a desired range (100 seconds ~ 400 seconds) at a
constant rotational speed. The percentage of plasma yield for each experiment was
recorded and plotted in Figures 3.10-3.12. When the separation process finished, the
motor was stopped and the quality of the extracted plasma was examined under an optical
microscope. A control experiment using similar centrifugal platform without microvalves
was carried out to prove the necessity to the microvalves.
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Figure 3.9: Blood separation. (a) 9.4 μl of the whole blood was loaded into the
device. (b) After separation, clear plasma was retained in front of the microvalve in
the supernatant reservoir, and the blood cells were centrifuged to the sedimentation
reservoir. A clear interface settled down in the sedimentation reservoir. (c) The inset
taken at the square area near the microvalve indicates how the blood cells
accumulate at one side. The diffusion of blood cells was restrained by the out-ofplane microvalve. The scale bar is 50 μm. (d) Optical microscope image of a spot in
supernatant reservoir showed only few blood cells there. The plasma purity can
reach up to 99.9%. The scale bar is 20 μm (e) Optical microscope image of a spot in
sedimentation reservoir. Blood cells are tightly stacked together. The scale bar is 50
μm.

3.4 Results and Discussion
The Lab-on-a-CD device was first characterized for its fabrication quality, and then was
evaluated according to performances of blood separation, which are plasma purity and
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plasma yield. Finally, the blood separation results of the centrifugal devices with and
without the microvalve were compared.

3.4.1 Device Characterization
The quality of the out-of-plane microvalves was evaluated through measuring the crosssectional profiles of the microvalves with a surface profilometer (Dektak). The profile
data were the average value of five measurements over the out-of-plane microvalve area
(Figure 3.8(c)) in the mold, and in PDMS casting, respectively. The surfaces of the
microstructure including the out-of-plane microvalve were smooth for both the mold and
the PDMS casting layer. The real dimensions of the device matched with the
anticipated/designed data (height ~45 μm, radial width ~250 μm) very well. The results
also indicated that the structure of the mold coincided with the PDMS casting layer.
Compared the reversed microvalve profile in the SU-8 mold with the microvalve profile
in PDMS casting, we found that they are overlaid in most part, while the microvalve
profile in PDMS was 2 ~ 3 μm lower in the height and 3 ~ 4 μm bigger in the width due
to deformation of the PDMS polymer. Another method of evaluation is to do SEM
imaging. In Figure 3.8(d), the SEM image shows the out-of-plane microvalve is smoothly
integrated into the microchannel, leaving a narrowed microchannel.

3.4.2 Performance of Whole Blood Separation
When the Lab-on-a-CD device rotated above the burst frequency estimated using
Equation 3.9, we observed the whole blood flow started to flow over the out-of-plane
microvalve. However the rotational frequency for the sedimentation process (> 1500 rpm)
was beyond the burst frequency of the microvalve, which was less than 1500 rpm in
calculation and about 1100 rpm observed in our experiments. During the sedimentation
process, due to the density difference between blood cells and plasma, they moved in two
opposite directions: the blood cells were prone to flow radially outward beyond the
microvalve to the sedimentation reservoir, while the plasma was pushed back into the
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supernatant reservoir. An interface, representing the abrupt discontinuity of blood cells
concentration, formed, and moved outward gradually. In our experiment, the motor was
controlled to stop when the interface moved across the microvalve and located in the
sedimentation reservoir. Further sedimentation process could not increase the plasma
yield in the supernatant reservoir because the extra separate plasma could only be
retained in the sedimentation reservoir. Figure 3.9(b) shows a clear plasma-cell interface
settling down in the sedimentation reservoir. The blood cells stacked densely in the
sedimentation reservoir, while purified plasma was on the other side of the microvalve
(the supernatant reservoir). The inset taken at the interface (square with dashed line in
Figure 3.9(b)) indicates how the blood cells accumulate at one side of the out-of-plane
microvalve (Figure 3.9(c)).

The blood separation performance of the devices was evaluated in terms of plasma purity
and plasma yield. The plasma purity (  P ) is defined as

 P  (CFC  CPC ) / CFC

(3.10)

where CFC is the cell concentration of the whole blood and CPC is the cell concentration
in the supernatant reservoir. A plasma purity of 100% implies that no cells exist in the
supernatant reservoir. The cell concentration can be approximately measured using
Count/Size function automatically by the Image Pro software of the Olympus microscope
indirectly. Thus the plasma purity is calculated based on the data acquired from the image
taken under the microscope. In this experiment, only few blood cells existed in the
supernatant reservoir (Figure 3.9(d)), and most of the blood cells stacked in the
sedimentation reservoir (Figure 3.9(e)). In addition, no clogging or hemolysis of cells
was observed under microscope. The obtained plasma purity was as high as 99.9% with
the out-of-plane microvalves restraining the cells diffusion.
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Figure 3.10: Plasma yield vs. rotation speed. The curve indicates the correlation
between plasma yield and rotation speed. The centrifugal force is proportional to
the square of the rotation speed. The higher the speed, the faster the plasma-blood
cells interface moves outward for a certain time period (200 seconds). Therefore the
plasma yield goes up as the rotation speed increases.

Plasma yield ( P ), the percentage of the separate pure plasma volume out of the total
plasma volume, is another important indicator of blood separation. It is defined as

 P  VP / VW (1  H ct )

(3.11)

where VP is the volume occupied by the pure plasma in supernatant reservoir, VW and Hct
are the volume and the known hematocrit (Hct, volume fraction of blood cells) of the
loaded whole blood, respectively. In order to reduce the sample consumption, as much
plasma as possible, in other words, a high plasma yield, should be achieved.
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Figure 3.11: Plasma yield vs. rotation time. The curve shows the plasma yield under
2000 rpm, with different rotation time. The longer the centrifugal force was exerted
on the blood sample, the further outward the plasma-blood cells interface moved.
Therefore the plasma yield rises as the rotation time increases.

The plasma yield is not only dependent on the efficiency of blood separation, but also
related to capability of a device for plasma collection. The higher efficiency of blood cell
sedimentation, the more plasma is squeezed out from the whole blood.

Only taking the efficiency of sedimentation into account, plasma yield is proportional to
the rotational time and the rotational speed of the CD platform. Figure 3.8 shows the
plasma yield of whole blood sample (48% Hct) after rotation of 200 seconds, reaching
88% at 2000 rpm and achieving better result (around 96%) at 2500 rpm. It suggests that
blood separation proceeded faster when the rotational speed was higher. However, the

63

speed of sedimentation decreased gradually in the post-separation process, because the
viscosity in the sedimentation reservoir increases as the concentration of blood cells
increases. On the other hand, when the angular velocity was held constant at 2000 rpm,
the plasma yield was proportional to the rotational time (Figure 3.11).

According to Equation 3.11, the plasma yield is proportional to the volume of plasma
contained in the supernatant reservoir. For the current device, the ability of plasma
collection is also related to the location of out-of-plane microvalves. To achieve the
highest plasma purity and plasma yield, the plasma-blood cells interface should be
located in the sedimentation reservoir and close to the microvalve. As the hematocrit of
the whole blood is normally less than 48%, the volume of sedimentation reservoir over
total loaded sample should be slightly larger than 48% (~50% in this work). Therefore,
there is enough space to store the blood cells in the sedimentation reservoir when the
separation process is thoroughly completed. In our experiments, the measured plasma
yield of current design of the device was 96 ± 0.5% for the whole blood samples of 48%
hematocrit.
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Figure 3.12: Rotational speed vs. rotational time for a predetermined plasma yield.
For a given rotational speed, each data point of time was collected when the plasmablood cells interface moved just across the microvalve. The images of the interface,
which help us to observe the movement of the plasma-blood cells interface, were
captured with the interval of 1 second without stopping the CD platform.

We also studied the relationship between rotational speed and rotation time (V - T) for
the same plasma yield (96%) (Figure 3.12). Controlling the rotational speed at a
predetermined value (x-axis), the time (y-axis) at which the plasma-blood cells interface
moved just across the microvalve was recorded. The data obtained can be well fitted by a
hyperbolic curve. Therefore, when the speed was too slow, the time required for blood
separation dramatically increased. On the contrary, the blood cells could be easily
separated if the speed was high. However, the rotational speed could not be ultimately
high, since the cells might be broken and lysed. We found that a rotational speed of 2000
rpm could achieve the best performance in terms of separation time and cell quality.
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The major contribution of the out-of-plane microvalve to Lab-on-a-CD devices for blood
analysis is to prevent the separated blood cells flowing/diffusing back and to maintain the
purity of the separated plasma. To demonstrate this core function of out-of-plane
microvalve, we made another Lab-on-a-CD device with the same design but without the
out-of-plane microvalve. Results of blood separation for both centrifugal platforms were
compared. The device without the out-of-plane microvalves was rotated on the motor at
2000 rpm for 250 seconds. The separated blood cells spread from the sedimentation
reservoir to the supernatant reservoir fairly fast right after the platform stopped. This cellflowing-back phenomenon was obvious and could be observed clearly by naked eyes.
Figure 3.13 shows the blood cell aggregates flowed in the opposite direction of the
sedimentation direction. They intruded the area where there was supposed to be an outof-plane microvalve, and took over the supernatant reservoir mixing with the purified
plasma. Actually, the blocking effect of the out-of-plane microvalve can be also found in
Figure 3.9(c). When the platform was still, some of the blood cells flowed towards the
microvalve. However, they were stopped by the microvalve, which ensures the purity of
plasma for subsequent operation and analysis.
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Figure 3.13: Blood cells reflowed back to the supernatant reservoir right after the
Lab-on-a-CD device without the out-of-plane microvalve stopped. Blood cell
aggregates flushed from the sedimentation reservoir, crossed the original valve area,
and back to the supernatant reservoir. a) at 10 seconds after the device stopped. b)
at 15 seconds after the device stopped. c) at 20 seconds after the device stopped. d) at
25 seconds after the device stopped. The circle tracks movement of the same cell
aggregate.
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3.4.3 Discussion
This Lab-on-a-CD design involves 3D structural microfabrication, but removes any need
to modify surface properties of microstructure or fill with exotic materials that required
by existing microvalving designs. 3D microfabrication is easy, low-cost and industrially
applicable. For mass production, hot-embossing or micro-injection molding can be used.
For prototype demonstration and laboratory test, the microfabrication method we used in
the present work is multi-step photolithography. In this method, 3D structure cast from
the multi-layer photoresists has higher alignment accuracy compared with conventional
multilayered PDMS structures that require well alignment of multiple PDMS layers. The
characterization results of the SU8 master and the fabricated PDMS layer suggest that the
present microfabrication method is suitable for the fabrication of Lab-on-a-CD device
with out-of-plane microvalves, and is highly reliable and replicable.

Complete blood separation not only means redistribution of blood components using
different physical field, but also requires isolation of different components to prevent
remixing. Therefore the spatial isolation of different blood components in Lab-on-a-CD
devices not only improves blood separation performance, but also help implement the
downstream blood analysis.
Two mechanisms can cause separated blood cells to flow back. One is diffusion due to
the concentration difference of blood cells between the sedimentation reservoir and the
supernatant reservoir. The other is the release of the accumulated elastic energy of
compressed blood cells. In the sedimentation process, blood cells aggregated and were
largely deformed under centrifugal force. Once the force vanished, the stored elastic
energy of the deformed and concentrated blood cells can push themselves back to the
supernatant reservoir. Therefore, the blood cells in the sedimentation reservoir were
prone to flow backward into purified plasma when the devices have no obstructions like
the out-of-plane micorvalves to stop them.
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The microvalve not only prevents the diffusion of blood cells from the sedimentation
reservoir back to the supernatant reservoir, but also breaks the liquid connection between
two reservoirs when the device stops. When it stopped after blood separation, the
existence of out-of-plane microvalves interrupted the connection of liquid in the
narrowed microchannel on top of the out-of-plane microvalve. As a result, the plasma in
the sedimentation reservoir was completely isolated from the blood cells in the
sedimentation reservoir.

This out-of-plane microvalve design can be easily integrated into any other centrifugal
platforms, and again lead many potential applications. For example, this out-of-plane
microvalve can be used together with the siphon microvalve [12] to facilitate plasma
extraction.

In summary, the present design of Lab-on-a-CD devices with the out-of-plane microvalve
provides a simple, fast and inexpensive approach for high-performance, on-chip blood
separation for whole blood. Figure 3.8(a) shows the whole set up of the system. A 12V
DC motor controlled by a laptop is enough to provide the required function of the
rotational speed over time. Besides its easy fabrication method and simple control
mechanism, the whole system is also portable, and allows parallel and multiple blood
sample treatment in one Lab-on-a-CD platform.
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3.5 Conclusions
This study has demonstrated a simple but highly effective design of Lab-on-a-CD device
integrated with out-of-plane microvalves for high performance whole blood separation.
99.9% of plasma purity and 96 ± 0.5% of plasma yield have been achieved for the whole
blood with 48% hematocrit. This design significantly improves the plasma yield, the
efficiency of blood separation of the whole blood, and the readiness of plasma usage for
subsequent blood testing. The 3D microfabrication of the out-of-plane microvalve(s) and
its integration into Lab-on-a-CD devices are simple, low-cost, and easy-to-beimplemented in both research laboratories and industry. The present design can also
provide a simple and possible solution for developing Lab-on-a-CD products using
optical analysis or electrochemical analysis after blood separation.
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Chapter 4
4 Design and Optimization of Prussian Blue/Carbon
Nanotube Electrodes for Biosensing Applications
In the last Chapter, a blood plasma separation process was successfully conducted on the
Lab-on-a-CD platform. Thereafter, the concentrations of blood contents in the separated
plasma can be detected with the electrochemical biosensors embedded in the plasma
reservoir. Electrochemical detection for point-of-care diagnostics is of great interest due
to its high sensitivity, fast analysis time and ability to operate on a micro/nano scale. This
work focuses on design and optimization of prussian blue (PB) and multi-wall carbon
nanotubes (MWCNT) based electrodes for electrochemical biosensing applications. The
factors that might affect the performance of the biosensor were evaluated. It was found
that the immobilization methods and the amount of GOx mainly influenced the sensitivity
of the glucose biosensor, while the amount of Nafion affected both the sensitivity and the
linear range of the glucose biosensor.

4.1 Introduction
Diabetes mellitus is the most common endocrine disorder of carbohydrate metabolism
that normally cannot be cured. It is a leading cause of morbidity and mortality, and its
prevalence is increasing. Blood glucose concentration is the major diagnostic criterion for
diabetes as well as a useful parameter for patient monitoring. Self-monitoring of blood
glucose has been established as a valuable tool for the management of diabetes. Regular
and frequent measurements of blood glucose have been found to provide data that
optimizes or changes patient treatment strategies, resulting in the development of a series
of glucose-measuring devices. Biosensing technology plays a key role in providing a
powerful analytical tool for glucose measurement [1]. This is a reason that many papers
focused on the enzyme-based glucose biosensors since Clark and Lyons reported their
enzyme electrode for measuring glucose in 1962 [2].
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The majority of the current glucose biosensors are of the electrochemical type due to their
excellent sensitivity, easy maintenance and low cost [3]. Electrochemical biosensors can
be subdivided into potentiometric, amperometric and conductometric types [4-5].
Enzymatic amperometric glucose biosensors are the most common devices that are
commercially available and have been widely studied over the past few decades.
Although different kinds of enzymatic amperometric glucose biosensors are available, the
basic concept of the glucose biosensor has changed little in principle. Initially, the
immobilized glucose oxidase (GOx) catalyzes the oxidation of β-D-glucose by oxygen,
producing gluconolactone and hydrogen peroxide [6]. This can be represented as
follows：
Glucose  O 2 GOD

 Gluconolactone  H 2 O 2

(4.1)

The concentration of glucose can be obtained by electrochemically detecting the
enzymatically liberated H2O2. However, the applied potential necessary for the oxidation
or reduction of H2O2 at solid electrodes is extremely high and increases the disturbance
from chemical interferences. Therefore, a modified electrode [7] or a transducer such as
peroxidase [8-11] and hexacyanoferrate [12-13] are usually used for the reduction of
H2O2 at low applied potentials. PB, whose composition is expressed as Fe4[Fe(CN)6]3, is
considered as an “artificial peroxidase” due to its high activity and selectivity toward the
reduction of H2O2. Its high chemical stability, facile preparation and rich electrochemical
properties make it effective in the application of biosensor [14-18]. However, PB is not
stable on the surface of bare electrodes in neutral solutions. Therefore, it is necessary to
electrodeposite a PB layer on modified electrodes [19] or co-electrodeposit with a
modifier [20] to improve its operational stability and increase its use in biosensor
fabrication.

Since discovered by Iijima [21], multi-wall carbon nanotubes (MWCNT) have been
widely used in the electrochemical field owing to their high chemical stability, large
surface area, unique electronic properties, and relatively high mechanical strength. Even
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more importantly, PB deposited on the MWCNT modified electrode was found to be
stable in neutral solutions. However, MWCNT possesses poor dispersibility in liquid,
especially

in

water,

which

greatly

hinders

the

corresponding

applications.

Poly(diallydimethylammonium) (PDDA), a water-soluble quaternary ammonium
polyelectrolyte, was reported to improve the dispersibility of CNTs in water [22-24].
Hence, PB was electrodeposited on a Au electrode that was modified with PDDA
wrapped MWCNT.

Immobilization of enzymes is a key step in the fabrication of glucose biosensors.
Methods based on covalent or cross-linking bonding [25-26], adsorption [27-28], and solgel techniques [29-30] have been reported. Glutaraldehyde is commonly employed as an
amine-reactive homobifunctional crosslinker, although it may cause the loss of enzyme
activity to some extent [31]. Chitosan [32-33] and nanoparticles [7, 34] were explored to
aid the immobilization of GOx in order to improve the performance of the glucose
biosensors.

In this work, MWCNT wrapped by PDDA were spread onto the surface of a Au electrode.
PB, as an electron mediator, was then electrochemically deposited on the MWCNT
modified electrode. GOx was immobilized on the PB/MWCNT/Au electrode and a layer
of Nafion was used to prevent GOx from leaking off and operated as a glucose diffusionlimited membrane. Based on this configuration, all the possible factors (pH values,
detection potentials, GOx immobilization methods, GOx amount and Nafion
concentration) that may affect the performance of the glucose biosensors were
investigated, and a method of manipulating their linear range and sensitivity was
developed.
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4.2 Material and methods
4.2.1 Reagents
The reagents were of analytical grade or the highest commercially available purity. All
chemicals were employed without further purification. All solutions were prepared with
deionized (DI) water with a resistivity that is higher than 18 M cm (Milli-Q, USA). D(+)-Glucose, GOx (Type X-S, 250 units/mg), human serum with glucose concentration of
5.4 (S2257-1ml), bovine serum albumin (BSA), iron (III) chloride, and potassium
ferricyanide (III) were purchased from Sigma. Different concentrations of glucose
solution were prepared in DI water and stored at 4 C (mutarotation was allowed for at
least 24 h before use). 20 mM phosphate buffer solutions (PBS) containing 0.1 M KCl
were freshly prepared everyweek. GOx was dissolved in PBS (pH 6.8) to a desired
concentration. Nafion (20 wt % in lower aliphatic alcohols) and PDDA (20 wt % in
water) were purchased from Aldrich. The MWCNT with 95% purity (purchased from US
Research Nanomaterials, Inc) are cylindrical with a diameter in the range 5 – 15 nm.

4.2.2 Apparatus
All electrochemical experiments in this work were performed on a computer-controlled
CHI1200a (CHI Instruments, Inc., USA). A gold working electrode (2 mm diameter), a
platinum wire counter electrode, a Ag/AgCl reference electrode with saturated KCl and a
conventional three-electrode electrochemical cell were all purchased from CHI
instruments, Inc., USA.
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4.2.3 Configuration of the biosensor
4.2.3.1 Preparation of a MWCNT-PDDA modified Au
electrode
The Au electrode was sequentially polished with 1.0 and 0.3 m alumina slurry on
microcloth pads. After removing the trace alumina from the surface by rinsing with DI
water, the electrode was ultrasonically cleaned for 10 min in a fresh Piranha solution
(H2SO4: H2O2 = 3:1(v/v)). The electrode was then ultrasonicated in DI water, ethanol, and
DI water again for 5 min each. Before depositing MWCNT, the electrodes were
electrochemically cleaned and activated in 0.5 M sulfuric acid by cycling between 0.4 V
and 1.6 V at a sweep rate of 40 mV s-1 until a stable voltammogram was obtained (Figure
4.1) [35]. MWCNT were hydrophilically functionalized by adding H2SO4 (98%) and
HNO3 (60%), which are in the volume ratio of 3:1 [36-38]. This treatment lasted for 8
hours, after which the acid solution from the supernatant was removed. In order to
neutralize the MWCNT solution, NaOH was added into the solution until its pH value
reached 7. The salts left with MWCNT were extracted by DI water in a procedure which
involved repeating the steps of adding DI water, centrifugation and removing supernatant.
MWCNT-PDDA composite was prepared in a 4 mL vial by adding 1 mL of PDDA (8%)
and 1 mg MWCNT, and ultrasonicated for about 1.5 hours. The PDDA residual was
removed using a high-speed centrifugation technique and the composite was washed with
DI water several times until the black stable solution was obtained [34, 39-40]. The
modified electrode was prepared by spreading 5 L of the MWCNT-PDDA solution over
the Au electrode surface and evaporating the solvent at room temperature.
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Figure 4.1: Electrochemical cleaning and activation of electrodes in 0.5 M sulfuric
acid by cycling between 0.4 V and 1.6 V at a sweep rate of 40 mV s-1.

4.2.3.2 Electropolymerization of PB film
Cyclic voltammetry (CV) was employed to deposit PB film on the surface of the
MWCNT modified Au electrode. The electropolymerization of PB was achieved by
immersing the electrode in an unstirred fresh solution containing 5 mM K3[Fe(CN)6], 5
mM FeCl3, 0.01 M HCl and 0.1 M KCl, followed by a 20 cycle scan in a potential range
of -0.1 to 0.4 V at 20 mV/s (Figure 4.2) [41-45]. After it was thoroughly washed with DI
water, the electrode was transferred into a supporting electrolyte solution (0.1 M KCl
containing 0.01 M HCl) and electrochemically activated by cycling between -0.1 and 0.4
V at 50 mV/s until the stable CV curves emerged (Figure 4.3) [46-48]. The
PB/MWCNT/Au electrode was cleaned again in DI water and tempered at 110 C for 1 h.
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Figure 4.2: Cyclic voltammograms of Pb electropolymerization.

Figure 4.3: Cyclic voltammograms of Pb activation.

80

4.2.3.3 Glucose biosensors constructed on PB/MWCNT/Au
electrode
When the PB/MWCNT/Au electrode was ready to use, the next step was to immobilize
the enzyme GOx. Different methodologies of immobilizing GOx were investigated to
improve the analytical performance. In the first method, GOx was immobilized with
chitosan. GOx-chitosan mixture consisted of 10 L GOx (10 mg/mL) and 10 L chitosan
(0.5%). 5 L mixture was dropped onto the PB/MWCNT/Au electrode. The second
method involved the cross-linking of GOx-chitosan mixture by adding glutaraldehyde.
The GOx-chitosan layer was dipped into 0.25% glutaraldehyde for 20 min. The third and
fourth methods were conducted in a similar way as the second one, but the mixture of
GOx-chitosan (0.5%, w/V) was replaced by the combination of GOx-BSA (1%, w/V) and
GOx-BSA-chitosan (0.5%, w/V), respectively. These four types of glucose biosensor
were completely constructed by casting 5 L Nafion on top of the GOx layer. Finally, the
biosensors were cleaned in DI water and stored overnight in a refrigerator (4 C) and
used the next day. When not in use, the biosensor was stored again in the refrigerator for
lifetime tests.

4.3 Results and Discussion
4.3.1 Morphology and structures of MWCNT/Au
A homogeneous, well-dispersed suspension of PDDA-MWCNT solution was stable for
several months. As shown in Figure 4.4a, the MWCNT-PDDA composite spreads evenly
on the surface of a Au electrode and the film is homogeneous and porous. In contrast, the
unmodified MWCNT form bundles (Figure 4.4b). The results show that PDDA aids the
dispersion of MWCNT and the resulting homogeneous and porous film of PDDAMWCNT is beneficial not only to the electrodeposition of PB but also to the
immobilization of GOx.
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(b)
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1um

Figure 4.4: SEM images of (a) PDDA-MWCNT composite and (b) unmodified
MWCNT on the surfaces of Au electrodes.
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4.3.2 Electrochemical behavior of PB/MWCNT/Au
MWCNT/Au electrode did not show any obvious redox peak, while the addition of PB
produced a pair of well-defined redox peaks with potential values in the range of 0.2 
0.25 V, which were ascribed to the redox of PB and PW (Prussian white) [49]. The CV
curves of PB/MWCNT/Au at various scan rates were shown in Figure 4.5a. With
increasing scan rate, both the redox peak currents and the peak-to-peak separation
increased. The anodic and cathodic peak currents were linearly proportional to the square
root of the scan rate from 30 mV/s to 300 mV/s, indicating that the redox of PB on
MWCNT/Au was a diffusion-controlled process (Figure 4.5b).

The existence of MWCNT can alter the electroanalytical performance of PB. MWCNT
possess larger electroactive surface area that could facilitate more PB polymerizing on
the electrode. Figure 4.6a compares the voltammetric peak current of a pure PB modified
electrode and a PB/MWCNT modified electrode in PBS with pH from 4.8 to 7.8. The
redox currents of PB/MWCNT modified electrode are larger than the pure PB modified
electrode in the whole pH range. The peak current value of the PB/MWCNT/Au
electrode at pH 6.8 was 30.57 A, about 2.5 times higher than that at the PB/Au electode
(13.00 A). Besides providing larger electroactive surface area, MWCNT alleviate pH
dependency of PB layer. It is well known that PB is unstable and dissolvable at pH above
7.0 [41], and the higher the value of pH in the solution, the lower the stability of the PB.
So far, only a few methods were tried to improve the stability of PB during the raising of
pH [9, 21]. As shown in Figure 4.6a, MWCNT retained the electrocatalytic property of
PB at higher pH value. The current of the pure PB modified electrode starts dropping at
pH 6.3, while the current generated by PB/MWCNT modified electrode does not
significantly decrease until pH 6.8. Even at pH 7.4 (the normal pH of human blood), the
current signal generated by PB/MWCNT modified electrode is still 80% of the one
generated at pH 6.8. The above data clearly show that MWCNT enhance the stability of
PB modified electrodes at high pH values. Since MWCNT modified electrode increased
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both the response and the stability of PB, PB/MWCNT modified electrode was selected
to fabricate glucose biosensors.

(a)

(b)
Figure 4.5: The cyclic voltammograms of PB/MWCNT/Au electrode at different
scan rates: 50, 80, 100, 150, 200, 250, and 300 mV/s in PBS (pH 6.8). (b) The
dependence of redox peak currents on the square root of scan rates.
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(a)

(b)
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(c)

(d)
Figure 4.6: (a) The effects of pH on the oxidation peak current of PB/Au and
PB/MWCNT/Au electrodes; (b) Cyclic voltammograms for the biosensor in the
absent of glucose and in the presence of 5 mM glucose. Scan rate 50 mV/s; (c) The
effects of pH on the sensitivity of the biosensor; (d) The effect of working potential
on the sensitivity of the biosensor. Data in (b, c, d) are based on the Nafion/GOxchitosan/PB/MWCNT/Au biosensors.
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4.3.3 Electrochemical behavior of the Nafion/GOxchitosan/PB/MWCNT/Au biosensor
The biosensor was first characterized in the presence or absence of glucose in a PBS (pH
6.8) (Figure 4.6b). In the absence of glucose, the biosensor only produced the
electrochemical response of PB itself. In the presence of 5 mM glucose, the reduction
current increased while the oxidation current dropped down, showing an electrocatalytic
behavior of PB in response to the reduction of H2O2 produced by the enzyme reaction.

The pH effect on the biosensor is twofold: the pH effect on the electrocatalytic property
of the PB layer and the pH effect on the bioactivity of GOx. Figure 4.6c illustrates the
combined relationship between the sensitivity of the biosensor (Nafion/GOxchitosan/PB/MWCNT/Au) and the pH values of the glucose solutions. The sensitivity
value represents the slope of the calibration curve that was obtained from the typical
amperometric response of the biosensor to successive addition of glucose into the stirring
PBS at 0 V applied potential. The results showed that the sensitivity increased from pH
4.7 to 5.3 and decreased little in the range of pH 5.3 to 6.8, following a sharp decrease
when pH was over 6.8. The maximum sensitivity was observed at pH 5.3 because of the
maximum activity of GOx and the stability of PB at this pH level. The decrease of the
sensitivity for pH over 6.8 is attributed to the decrease of both PB stability and GOx
activity. PBS of pH 6.8 was chosen as bulk solution for the following optimization
experiments because this pH value not only provided strong response, but is also closed
to the pH value of whole blood sample.

Similar to the optimization process of pH value, the sensitivity of the biosensor was
recorded in diverse applied potentials and a fixed pH value (6.8). Figure 4.6d shows that
the sensitivity varied in the range from -0.2 to +0.2 V (vs. Ag/AgCl), reaching its largest
value around 0 V. The increased sensitivity with applied potential can be attributed to the
increased driving force for the reduction of ferric ferrocyanide which was produced
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during the redox reaction. Meanwhile, this applied potential also results to a maximum
ratio between glucose current and background current (S/B) [50]. Taking into account the
high response sensitivity and low background noise, a potential of 0 V was chosen as the
applied potential for the following chronoamperometry measurements.

4.3.4 Investigation on the linear range and the sensitivity of
glucose biosensors
4.3.4.1 The effect of enzyme immobilization methods
As mentioned in section 4.3.3, GOx was immobilized on the PB/MWCNT/Au electrode
using four representative methods to investigate how different methodologies of enzyme
immobilization affected the sensitivity and linear range of the glucose biosensors. In the
first method, GOx was immobilized in the chitosan matrix through physical absorption,
which is a non-specific physical interaction, involving Van der Waals or dispersion
forces. This method can be easily performed, and tends to be less poisonous to the
bioactivity of enzymes compared to chemical means of attachment. Due to the low
strength of the non-specific interaction, desorption of enzymes during the measurement
process appears to be a primary problem.

In order to solve this problem, GOx was attached to the support matrix by covalent
bonding, which was formed between functional groups on the enzymes and those on the
support surface. As chitosan contained abundance of amino that was able to react with
aldehyde from glutaraldehyde to form a structure of gel, the GOx-chitosan mixture was
cross-linked with glutaraldehyde to provide insolubilized and stable enzyme derivatives
that prevented enzymes from leaching into the surrounding solution.

Glutaraldehyde can also lead to the cross-linking of enzyme molecules, creating an
insoluble, reticulated, and rigid cluster. The enzyme insolubilization may change the
molecular conformation of the enzymes by bonding the active site of enzymes, leading to
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the denaturation of the enzyme protein. The cross-linking process can be conducted with
the aid of an inert protein to increase the stabilization of the enzymes after it is
immobilized. Here, BSA was added into the GOx-chitosan mixture to diminish
deactivation during the cross-linking phase and increase GOx stability. Unfortunately, the
cross-linking process catalyzed by glutaraldehyde induced the formation of diffusion
barriers, which could have impaired the sensitivity of the biosensor. Thus, to thin down
the enzyme layer, only the GOx-BSA mixture was cross-linked with glutaraldehyde.

Figure 4.7a shows the current-time response curves of four types of biosensors (Nafion
0.5%, GOx 10U). The sensitivity changed dramatically in the four glucose biosensors
because the activity of GOx was varied under different immobilization methods of GOx.
The combination of GOx-BSA/glutaraldehyde achieved the highest sensitivity (1.02
µA/mM), while the GOx-BSA-chitosan/glutaraldehyde showed the lowest sensitivity
(0.28 µA/mM). However, the linear range of the four glucose biosensors was narrow and
changed little (Figure 4.7b). Thus, other factors should be investigated to broaden the
linear range of the glucose biosensors.
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(a)

(b)
Figure 4.7: The current-time response curves (a) and their calibration curves (b) of
biosensors fabricated using four kinds of enzyme immobilization methods: a GOxchitosan without cross-linking; b, c and d GOx-chitosan, GOx-BSA and GOx-BSAchitosan, cross-linked with glutaraldehyde. PBS (pH 6.8) and working potential (0 V)
were applied in the experiments.
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4.3.4.2 The effect of the amount of GOx
The amount of GOx was reported to influence the performance of glucose biosensors
(Tsai et al., 2005). The effect of the amount of GOx on the sensitivity and the linear range
of Nafion/GOx-BSA/PB/MWCNT/Au (5 L 10% Nafion) was investigated in the range
of 5 – 15 U (Figure 4.8). The sensitivity of glucose biosensor increased when the amount
of GOx increased from 5 U to 10 U. However, the sensitivity decreased when the amount
of GOx was above 10 U. This phenomenon could be explained through the inverted
relationship between the number of active sites and inhibitors. Increasing the GOx
concentration increased the number of active sites and consequently decreased the
number of inhibitors. As more active sites were involved in the conversion of glucose
molecules into H2O2 in a given time period, the sensitivity increased. If the amount of
enzymes present had exceeded the amount of glucose molecules in the local surface, the
further increase of enzyme concentration would not speed up the enzymatic reaction. On
the contrary, the diffusion of H2O2 to the catalyst layer would be hindered by the thick
enzyme layer, which would decrease sensitivity of the glucose biosensor. Although the
amount of GOx could change the sensitivity of the glucose biosensors, it rarely affected
their linear range (Figure 4.8b).

91

(a)

(b)
Figure 4.8: The current-time response curves (a) and their calibration curves (b) for
the Nafion/GOx-BSA/PB/MWCNT/Au at the amount of GOx of (A)15 U, (B)10 U
and (C) 5 U. PBS (pH 6.8) and working potential (0 V) were applied in the
experiments.
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4.3.4.3 The effect of diffusion-limited membrane
Nafion has been widely used as an electrochemistry promoting polymeric binder in the
fabrication of glucose biosensors to prevent the leakage of GOx and the interference.
Nafion can be also used as a diffusion-limited membrane to adjust the diffusion velocity
of substrate (here is glucose). The effects of Nafion concentrations, in the range of 0.5% 10%, on the sensitivity and the linear range of the glucose biosensor (GOxBSA/PB/MWCNT/Au) were studied. It was shown that the sensitivity of the glucose
biosensor decreased rapidly with the increase of Nafion concentration, but the linear
range was significantly widened (Table 1).

The enzyme reaction layer and the bulk solution were separated by the Nafion membrane.
Prior to reaction the molecules of glucose from bulk solution diffused through the
membrane to reach the surface of the enzyme layer. The rates at which the glucose
molecules passed over the semi-permeable membrane determined the concentration of
glucose in the proximity of enzymes. Based on the response dynamics of enzymes, the
response of GOx on glucose is only linearly dependent in low concentrations of glucose.
When Nafion was used as a diffusion-limited membrane, the diffusion rate of glucose
decreased with the increase of Nafion concentration. The linear range of the glucose
biosensor was wider and the sensitivity was lower in a higher concentration of Nafion
due to the low concentration of glucose in the enzyme layer. Therefore, the concentration
of Nafion could be chosen based on the actual situation. For example, a low
concentration of Nafion could be chosen to increase the sensitivity of the biosensor, while
a high concentration of Nafion could be chosen to widen the linear range of the biosensor.
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Table 4.1: The effect of Nafion concentration on the sensitivity and linear range of
the biosensor.
Nafion

Sensitivity Linear range Detection limit

concentration

(A/mM)

up to (mM)

S/N=3 (mM)

0.5%

1.02

2.4

0.08

1%

0.17

8

0.1

10%

0.02

20

0.8

4.3.5 Interference
The current response of Nafion/GOx-BSA/PB/MWCNT/Au (1% Nafion, 10 U GOx) to
the possible interference was shown in Figure 4.9. The interference from ascorbic acid,
uric acid, and lactic acid were negligible. The selectivity of the glucose biosensor was
high because Nafion film can effectively prevent the interference of cations and the low
working potential of the glucose biosensor, 0 V, prevents the normal interference from
oxidation or reduction.
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Figure 4.9: Current response of Nafion/GOx-BSA/PB/MWCNT/Au to different
substances: (a) 1 mM glucose, (b) 0.6 mM ascorbic acid, (c) 0.6 mM uric acid, (d) 0.6
mM lactic acid, (e) 1 mM glucose. PBS (pH 6.8) and working potential (0 V) were
applied in the experiments.

4.3.6 The application of glucose biosensor
The application of the glucose biosensor was evaluated by the presence of glucose in
human serum. 0.1 mL of serum was added into 5 mL of PBS. The glucose concentration
in the sample was detected as 5.7 mM with a RSD of 5.5% (n = 5). The recovery was
obtained by a standard addition method. The glucose biosensor demonstrated satisfactory
results with the recovery rate in the range of 98% - 103%. The satisfying results showed
that the biosensor has a great potential for practical application, retained its enzyme
bioactivity and reproduced 85% of its initial sensitivity after it was stored in PBS at 4°C
for two weeks.
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4.4 Summary
The linear range of conventional glucose biosensors was normally narrowed under 2 mM,
but the blood glucose concentration of diabetes mellitus patients could achieve over 20
mM. The majority of research only focuses on increasing the detective sensitivity of
glucose biosensors, and little attention has been focused on their liner range [51].
Although biosensors cannot possess high detection sensitivity and a wide linear sensing
range at the same time, their sensing performance should be variable according to
practical applications.

This Chapter provides comprehensive information about the PB/MWCNT based glucose
biosensors. It was found that MWCNT wrapped by PDDA formed a uniform and porous
structure on a Au electrode that increased the response and stability of PB under various
pH values and improve the immobilization of glucose oxidase (GOx). The
immobilization methods and the amount of GOx mainly influenced the sensitivity of the
glucose biosensor, while the concentration of Nafion affected both the sensitivity and the
linear range of the glucose biosensor. The widest linear range of the glucose biosensors
was from 0.8 mM to 20.0 mM with a sensitivity of 0.02 A/mM, and the highest
sensitivity of the glucose biosensor was 1.02 A/mM with a linear range of 0.1 - 2.4 mM.
The biosensor showed little interference resulting from the possible interferents,
including uric acid, ascorbic acid and lactate because of the low operating potential,
indicating an excellent selectivity. Finally, the biosensor was used in the determination of
glucose in human serum, resulting in 5.5% deviation from the reference value.

As stated above, the measurements of human serum were conducted using PBS (pH 6.8).
At this pH environment, the biosensor possesses high sensitivity and strong response,
which can provide more information for the optimization of the biosensor. Certainly,
there is still a need to improve the performance of the biosensor at pH 7.4 for point-ofcare diagnostics.
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4.5 Conclusions
An amperometric glucose biosensor based on PB/MWCNT was developed. The effect of
enzyme immobilization methods, the amount of GOx and the concentration of Nafion on
the sensitivity and linear range of the glucose biosensor was investigated in detail. This
study developed a method to manipulate the sensing sensitivity and the linear range of
glucose biosensors according to diverse applications.
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Chapter 5
5 Fabrication of Nanoporous Thin-film Working Electrodes
and their Biosensing Applications
As the electrode system is directly embedded in the microfluidic system, it may
experience sample flow rates from nl s-1 to liter s-1 in the centrifugal platform. Here, a
nanoporous structure was created on the surfaces of electrodes through an
alloying/dealloying process. The nanoporous electrode has an electroactive surface area
up to 60 times higher than that of a flat gold electrode of the same size. Abundant
catalysts and enzymes were stably entrapped in the nanoporous structure, leading to high
stability and reproducibility of the sensor.

5.1 Introduction
Lab-on-a-chip technology has attracted researchers from different disciplines to explore
this technology for a wide range of applications [1-5]. Enzymatic electrochemistry is one
of the most applied detection techniques used in lab-on-a-chip devices to miniaturize
chemical and biological analysis processes due to its low cost, high sensitivity, moderate
power requirements, and prominent compatibility with microfabrication technologies [68]. Although the miniaturization will not alter the mechanism of biochemical reactions on
electrodes, will change fluid mechanics, molecular diffusion and surface to volume ratio
in micro scale channels and will require the modification of bulk electrochemical
biosensors.

In all types of enzymatic electrochemical biosensors, electrodes (working electrode,
reference electrode and counter electrode) perform as transducers, which convert
information of the specified amount of a biological analyte into an electrical signal. The
biorecognition phenomenon and the redox reaction occur on the surface of the working
electrode where the catalyst layer, the enzyme layer and the semi-permeable layer are
superimposed. Therefore, the working electrodes employed in microfluidic chips deserve

105

considerable attention. To fit the electrode in the detection chamber and to minimize the
disturbance to fluid movement, the thickness of the embedded planar electrode must be
reduced to nanoscale and the surface area must be as small as possible. However, the
miniaturization results in several implications that require further improvement. For
example, the miniaturization impairs the signal-to-noise ratio and the nanoscale thickness
of the metal layer limits the choice of surface functionalization for subsequent coating.
Because of the increasing demand for applying electrochemical sensing on Lab-on-a-chip
devices, the electrochemical sensing surface is expected to be thinner and possess a
higher signal-to-noise ratio.

Efforts have been made to enhance the sensing sensitivity through artificially enlarging
the surface area of working electrodes. Recently, porous materials prepared by a sol-gel
method have been developed to immobilize enzymes [9-10]. Nanostructured materials
have also attracted much attention due to their inherently large surface area. For example,
carbon nanotubes, which were randomly or uniformly immobilized with enzymes, were
used in the configuration of biosensors [11]. Metal nanoparticles and nanowires were also
prevalent selections for substrate materials [12]. However, these matrices have limitations,
including fragility, poor adhesion to the electrode surfaces and complicated fabrication
procedures, which may lead to the loss of enzyme activity and poor performance in
electrochemical biosensors.

Herein, a planar nanoporous thin-film working electrode was introduced for the first time.
The nanoporous structure is constructed within a 100 nm thick gold (Au) electrode rather
than adding another layer on top, reducing the total thickness of all layers (the metal layer,
the catalyst layer, the enzyme layer and the semi-permeable layer) that stack on the
electrode surfaces and improving the bonding among layers. This working electrode
design was applied in the construction of planar enzymatic electrochemical biosensors.
As hydrogen peroxide (H2O2) is a common byproduct in oxidase enzyme reactions,
Prussian Blue (PB) was used as a redox mediator to enhance the selectivity of H2O2
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detection on working electrodes [13]. We found that the nanoporous working electrode
not only possesses a large surface area, but also is an excellent substrate to hold enzymes
and catalysts. In the following sections, the fabrication and characteristics of the
nanoporous and planar thin-film electrodes are described, whilst the electrochemical
sensing of glucose is reported as an example to demonstrate the superior performance and
robustness of such biosensors.

5.2 Experimental Section
5.2.1 Materials and Equipments
D-(+)-glucose, uric acid, sodium L-lactate, ascorbic acid, glucose oxidase (100 - 250
U/mg), Nafion (5 wt. %), human sera (S2257-1ml), glucose (GO) assay kit and benzyl
alcohol (anhydrous, 99.8%) were purchased from Sigma-Aldrich. Piranha solution was
made using H2O2 (30%) and H2SO4 (conc) solution in 1:3 vol/vol ratio. All processing
solutions were prepared with de-ionized (DI) water from a Milli-Q system (Millipore,
Bedford, MA) and all other chemicals were of analytical grade. 20 mM phosphate buffer
solutions (PBS) with 0.1 M KCl were adjusted to pH 5.1. Standard samples were
prepared through the dissolution of D-(+)-glucose in PBS. The samples were mutarotated
overnight, forming an equilibrium mixture that consists of approximately one-third -Dglucose and two-thirds β-D-glucose. Human serum samples were made by dissolving
lyophilized sera with 1 ml DI water. A nanoporous thin-film working electrode, a
Ag/AgCl reference electrode in 1 M KCl and a Pt counter electrode comprised the
electrochemical sensing system. Electrochemical measurements were conducted using a
potentiostat (CHI 1207A, CH Instruments, Austin, TX) at room temperature (22 ± 1°C).
A Hitachi S-4500 field emission scanning electron microscope coupled with an energy
dispersive X-ray spectroscope (SEM/EDX) and a Veeco atomic force microscope (AFM)
were employed to characterize the fine structure of electrodes. A UV-visible
spectrophotometer from Varian was employed to provide a reference glucose level in
serum samples using a standard glucose assay kit.
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5.2.2 Fabrication of Nanoporous Thin-film Electrodes
Nanoporous thin-film electrodes were fabricated by selectively dissolving the less noble
metal from a bimetallic alloy. The alloy was made by consecutively depositing Au and
Zn (zinc), followed with thermal annealing. Prior to the metal deposition, a silicon wafer
was cleaned with piranha solution at 80°C for 20 min. The pattern of the working
electrode was defined by a positive photoresist Shipley 1805 on the cleaned wafer, which
was then loaded into an electron beam evaporation chamber and successively deposited 5
nm Cr (chromium) and 100 nm Au, where Cr served as an adhesive layer. The sample
was taken out, and the lead and conductive pad were covered with a piece of tape.
Afterwards, the sputtering technique was applied to deposit 500 nm Zn. After a lift-off
process, where the metal in the non-electrode area was removed using a PG remover (NMethyl Pyrrolidinone), the sample was annealed in benzyl alcohol at 100°C for 60 min
and rinsed with isoproponal (IPA) and DI water. Finally, the alloyed samples were
dipped into 50% HNO3 for 2 min to chemically dissolve the Zn.

5.2.3 Deposition of Prussian Blue, Enzyme and Nafion
Electrodeposition of PB was accomplished using cyclic voltammetery (CV) [13]. Before
the electrodeposition, the nanoporous electrodes were electrochemically cleaned and
activated in 0.5 M sulfuric acid by cycling between 0.4 V and 1.5 V at a sweep rate of 40
mV s-1 until a stable voltammogram was obtained. The solution for the electrodeposition
of PB comprises 1.5 mM K3[Fe(CN)6], 2 mM Fe(NO3), 1 mM HCl and 0.1 M KCl. The
electrode potential was cycled thirty times from 0.6 V to -0.2 V at a sweep rate of 50 mV
s-1. Subsequently, the electrodes were rinsed with DI water and activated in 0.1 M KCl +
0.1 M HCl by cycling the applied potential between 0.5 V and -0.2 V with scan rate of 50
mV s-1 until stable CV curves were obtained.

Glucose oxidase (GOx) was immobilized onto the PB-modified electrode surface by
physical adsorption. The lyophilized GOx powder was dissolved in PBS to form an
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enzyme solution with a concentration of 20 mg/mL. 5 µL of the enzyme solution was
dropped onto the electrode surface and dried in a fridge (4°C). Nafion solution of 5% was
added on top of the enzyme layer to protect against the leakage of the enzymes and
reduce the influx of glucose. The Nafion solution dried in the fridge as well. With these
steps, the biosensor was completely built and ready to be used immediately or stored in
PBS in the fridge.

5.3 Results and Discussion
The results presented here show that the nanoporous electrode is of excellent film quality,
large electroactive surface area, and high electrical conductivity. It is these qualities that
make it a robust platform for the immobilization of catalyst and enzymes and provides
excellent performance in biosensing trials.

5.3.1 Characterization of nanoporous thin-film electrodes
The formation of nanoporous structures on the working electrode layer is the key to their
superior performance. The sputtered Zn layer covering the Au layer was shiny and grey
before annealing. The sample turned to dark grey at the end of the annealing process,
which indicated the successful alloying. Annealing was conducted in benzyl alcohol to
prevent the oxidization of Zn to ZnO, which stops the alloying process. In the following
dealloying process, the Zn component was dissolved by nitric acid and the remaining Au
component gradually diffused to the surface to form bundles, which could further
develop into an interconnected porous network. The golden color of the surface turned
into a dim copper-like color at the moment the nanoporous structure was formed. As
shown in Figure 5.1, the smooth gold film electrode (Figure 5.1a) turned into nanoporous
structures (Figure 5.1b) after the dealloying treatment. The nanoscaled ligaments and
nanoporous are continuously connected to form a honeycomb structure, which not only
enlarges surface area, but also is an excellent substrate for electrode modification. From
AFM images (Figure 5.1c and 5.1d), we can see that the roughness was increased from 2
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nm for the planar gold to 20 nm for the nanoporous gold. Further, all the Zn atoms should
be removed, otherwise, the electrochemical signal would be disturbed by the leftover Zn.
In order to remove Zn without destroying the ultrathin nanoporous Au film, EDX
analysis was utilized to inspect the composition of the film and optimize the immersion
time of samples in the HNO3 solution. The EDX spectrum in Figure 5.2a shows that only
1.55% Zn remained in the nanopores films after immersing the sample in the HNO3
solution for 120 sec. The concentration of Zn changed little by further increasing the
etching time in the HNO3 solution. Explanation for this phenomenon is that the porous
film containing a small amount of Zn possessed similar corrosion behavior as that of pure
gold. Therefore, Zn atoms would not be selectively etched to the extent of 100% without
destroying the porous structure [14].
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(a)

(b)

600nm

300nm

(c)

(d)

Figure 5.1: SEM and AFM images show (a, c) the smooth and flat surface of a gold
electrode before nanoporous treatment; (b, d) the nanoporous surface of a gold
electrode after nanoporous treatment.
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(a)

(b)

Figure 5.2: (a) The EDX spectrum of a nanoporous electrode immersed in 50%
HNO3 solution for 120 sec. (b) Cyclic voltammograms recorded in 0.5 M H2SO4 for
a flat Au electrode and nanoporous Au electrode show that the cathodic peak of the
non-porous Au electrode is only one fortieth of that of the nanoporous Au electrode.
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It is known that nanoporous electrodes possess larger surface area than flat electrodes.
Among various determining methods, the method based on the reduction of gold oxide,
the charge of which is proportional to the active surface area, appears to be
straightforward [15]. Cyclic voltammograms of a flat Au electrode and a nanoporous Au
electrode were recorded in a 0.5 M H2SO4 solution and are compared in Figure 5.2b.
These voltammograms reveal that the formation of gold oxide results in the peak of the
current at the anodic scan, while the reduction of gold oxide induces the cathodic peak at
0.88 V. The electroactive surface area of the nanoporous electrodes was estimated to be
about 60 times larger than the flat non-porous Au electrode by measuring the area of the
cathodic peaks in the potential-current curves.

The nanoporous structure not only has a larger surface area, but also serves as an
excellent substrate for electrode modification. The electrodeposited microcrystalline PB
powder was firmly and evenly entrapped and distributed on the nanoporous surface
(Figure 5.3a), although the PB film electrodeposited on the flat Au electrode was lumpy
and full of cracks (Figure 5.3b). When the electrodes were cycled twenty times in the
PBS from 0.5 V to -0.2 V at a scan rate of 50 mV s-1, the majority of PB powder
remained on the nanoporous surface (Figure 5.3c), but a large amount of crystallized PB
was stripped off from the flat electrode surface (Figure 5.3d). This merit of the
nanoporous electrode significantly increases the stability and reproducibility of the
biosensor.
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(a)

(b)

(c)

(d)

Figure 5.3: SEM images of uniform and compact PB film deposited on a
nanoporous electrode (a) and subjected to twenty cycles in a PBS (c); lumpy and
loose PB film deposited on a flat electrode (b) and subjected to twenty cycles of
potential scan in a PBS (d) All the scale bars are 1 µm.

Before detecting biological samples, the nanoporous electrode with the PB layer was
characterized using cyclic voltammetry in the PBS. The PB films were characterized with
a benchmark compound Fe3+/Fe2+ redox couple and showed electrochemical behavior
(cyclic voltammetry) as follows:
Fe III 4 [Fe II (CN) 6 ]3 4 K   4 e   K 4 Fe II 4 [Fe II (CN) 6 ]3

(5.1)

In a forward scan from 0.5 V to -0.2 V with scan rate of 25 mV s-1, ferricyanide was
reduced to ferrocyanide and reached a cathodic peak current at 0.16 V. In a return
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potential scan, a reversed electron transfer reaction occurred and reached an anodic peak
current at 0.26 V (Figure 5.4a). The peak values of the forward and reversed reactions are
linearly proportional to the square root of the scan rates in the range from 25 to 500 mV s1

(Figure 5.4b). The linearity implies that the rate of the redox reactions is controlled by

the diffusion of potassium ions, which produces a concentration gradient of the
electroactive species in the PB lattice on the planar electrode. The rate of the electron
transfer step is fast compared to the rate at which potassium ions diffuse from the bulk
solution to the electrode surface, so the peak current, ip, is governed by the Randle-Sevcik
relationship [16-17].
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(a)

(b)

Figure 5.4: (a) Cyclic voltammogram of the PB-modified nanoporous electrodes at a
scan rate of 25 mV s-1 in the PBS; (b) The plot of anodic and cathodic currents vs.
the square root of the scan rates. The regression equation of the linear fit to anodic
response is: y=-0.74+0.26x (R2=0.9984, n=5), and to cathodic response is: y=0.440.28x (R2=0.9998, n=5).
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5.3.2 Calibration of the Biosensor
The mechanism of the sensor involves the electrochemical detection of H2O2 generated
by the analyte in the enzymatic reaction. Here, we take the specific biorecognition of
glucose by the enzyme glucose oxidase (GOx) as an example. GOx, containing two
molecules of the cofactor flavine adenine dinucleotide (FAD), is a homodimer with a
molecular weight of 160 kD. The sensing process can be elaborated as follows: glucose
diffuses from the bulk solution to the GOx layer where it is converted into
gluconolactone under the reduction of the FAD prosthetic group (Equation 5.2). The
cofactor is oxidized back to its original state, whereby two electrons and two protons are
transferred to molecular oxygen, generating H2O2 (Equation 5.3). The H2O2, which is
proportional to the concentration of glucose [18], then catalytically reacts with the
Prussian white (PW) by oxidizing PW to PB and PB itself is, in turn, electrochemically
reduced back to PW under the applied potential on the surface of the working electrode
(Equation 5.4).

GOx(FAD)   - D - glucose  GOx(FADH2 )   - gluconolactone

(5.2)

GOD(FADH2 )  O 2  GOD(FAD) H 2 O 2

(5.3)

K 2 Fe 2 Fe 2 (CN) 6  2H 2 O 2  KFe 3 Fe 2 (CN) 6  K   2H 2 O  O 2

The

biosensors

were

first

calibrated

with

standard

glucose

samples

(5.4)
using

chronoamperometry. In the chronoamperometric measurement, the potential of the
working electrode is stepped, so that the Faradic current occurs at the electrode and
decays as a function of time. The Faradic current, due to the electron transfer, is
proportional to the concentration of analyte, and can be described by the Cottrell equation
(for planar electrodes) [19]:

nFAC 0 D1 / 2
i
(t )1 / 2

(5.5)
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Where i is the current, n is the number of electrons, F is Faraday's constant, A is the area
of the electrode, t is the time, C0 and D are the initial concentration and the diffusion
coefficient of the target analyte, respectively.
The potential of 0 V (versus Ag/AgCl) has been optimized for cathodic reduction of
hydrogen peroxide aided by PB [16]. Therefore, chronoamperometric measurements
were carried out on glucose standard samples with concentrations ranging from 0 mM to
40 mM using 0 V step potential. In Figure 5.5a, the Faradic current occurs right after a
large capacitive current and decays as t-1/2 until its steady state. The steady state currents
at 100 sec were picked up to draw a calibration curve for this biosensor. The mean and
the relative standard deviation were generated with a group of data from five biosensors.
The calibration curve (square dots) in Figure 5.5b demonstrates the linear relationship
between currents and analytes with a concentration of 0 - 30 mM (R2 = 0.9971, n = 5).
The signal for 40 mM is out of the linear range. This linear range has been able to cover
the entire normal human blood glucose of 3.5 – 6.1 mM (in whole blood) and abnormal
glucose levels (20 – 30 mM). The sensitivity of the glucose analysis is calculated to be
0.50 µA mM−1 mm−2, higher than the value (0.43 µA mM−1 mm−2) achieved by the
electrochemical system built on the porous paper [20]. The limit of detection (LOD),
calculated as the concentrations which produced a signal of three times greater amplitude
than noise (S/N = 3), is about 0.3 mM, providing better performance compared to the
conventional colorimetric methods (LOD, 0.5 mM) and glucometers (LOD, 1 mM) [2122]. The conventional flat electrodes with immobilized enzymes were also measured
using the same condition, and the data were plotted in Figure 5.5b (circular dots). The
result of the comparisons clearly shows that the nanoporous biosensor possesses higher
sensitivity than conventional biosensors. The increase of electroactive surface area (A)
results in sensitivity enhancement, which is supported by the Cottrell equation.
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(a)

(b)

Figure 5.5: (a) Chronoamperograms of glucose with concentration from 0 mM to 40
mM. The working electrode with a diameter of 3 mm was used to record data at 0 V
versus Ag/AgCl. (b) Currents of chronoamperometric curves at 100 seconds plotted
as a function of the concentration of glucose. Square dots and circular dots
represent data from nanoporous biosensors and conventional biosensors,
respectively. The regression equation for the linear fit is: y=25.71+3.19x (R2=0.9971,
n=5).
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5.3.3 Analytical performance
Human serum samples were assayed in order to validate that the nanoporous thin-film
electrochemical system is beneficial to the practical usage of the glucose biosensor. The
glucose concentrations of these serum samples were measured based on a
spectrophotometric method using a standard test kit, and used as reference values. The
steady state currents of serum samples were then collected in the same condition as in the
calibration step, and the glucose concentration was calculated using the previous
calibration curve. The measured value with the spectrophotometric method was
5.43±0.08 mM, whilst it was 5.51±0.03 mM with the electrochemical method using the
biosensor. The approximation of these two values proves the practical utility of the
proposed biosensor. The robustness of the biosensor was further proved by showing the
recovery of glucose concentration by a standard addition method. The recovery rates
were in the range of 96% - 103% for human serum samples spiked with 0.5 mM glucose.
In addition, the biosensor retained its enzyme bioactivity and still had about 80% of its
initial sensitivity after 10 days stored in PBS at 4°C.

As an inherent merit of using PB, the biosensor showed little interference to the
electroactive interfering compounds commonly present in physiological samples,
including lactate (LA), uric acid (UA) and ascorbic acid (AA) due to the low operating
potential. The utilization of Nafion as an outermost layer on the electrode surface further
ensures its sensitivity to glucose by dramatically reducing the diffusion of interfering
compounds to the electrode surface. The normal concentrations of LA, UA and AA in
serum are 0.2 mM, 0.3 mM and 0.1 mM, respectively. The amperometric response of the
biosensor to successive addition of glucose (0.5 mM) and the interferents into the stirring
PBS is shown in Figure 5.6. The current rose only 0.7% and 0.3% during the additions of
0.2 mM lactate and 0.3 mM uric acid (UA), while the presence of 0.1 mM ascorbic acid
(AA) slightly depressed the current by about 1.5%. The two additions of 0.5 mM glucose
before and after the existence of those interferents produced an equivalent response, so
the summation of interferents did not denature the biosensor. These results demonstrated
the excellent anti-interference ability of the biosensor.
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Figure 5.6: Amperometric response to successive adding of glucose and interferents.
The experiment was conducted in the stirring PBS at 0 V versus Ag/AgCl. Under
this condition, the adding of 0.2 mM lactate (LA), 0.3 mM uric acid (UA) and 0.1
mM ascorbic acid (AA) introduced 0.7% and 0.3% increasing, and 1.5% decreasing,
respectively.

5.3.4 Discussion
The fabrication and application of nanoporous structures have been reported in bulk
electrodes by other researchers, but the fabrication of nanopores in a thin-film planar
electrode and its application in electrochemical detection are conducted here for the first
time.

Modification of electrodes through layer by layer assembly of organic and inorganic
material possesses the inherent adhesion problem between the assembled layers and the
flat electrode surface, and so the risk of the catalysts/enzymes being washed out of the
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modified electrodes or leached into the solution is increased, which impairs the stability
and performance of the electrode system. It is also known that the PW (the reduced form
of PB) at potentials around 0.0 V is unstable and hydroxyl ions produced by the reduction
of H2O2 in neutral media make the inorganic polycrystal partially soluble, so the
electrodeposited PB could easily strip off from the flat electrode surface, leading to the
loss of the electrocatalyst [23-24]. In this experiment, blue pigment could be observed by
naked eyes due to the detachment of PB from the flat electrode surface whether using the
cyclic voltammetric deposition technique or the constant potential deposition technique.
However, this rarely happens on nanoporous electrodes, as most of the deposited PB film
is firmly entrapped in the nanopores.

The nanoporous structure not only can firmly hold PB particles during the electrode
modification process (Figure 5.3), but also benefits from retaining enzymes when the
biosensor is integrated in microfluidic system. Sample flow rates in the microfluidic
system normally range from nL s-1 to L s-1 [4]. When it flows across the conventional
working electrodes, the sample fluid will continuously bring away portions of the
immobilized enzymes, resulting in a decrease of the stability of biosensors. Here, we
designed an experiment to compare the performance of a nanoporous biosensor and a
conventional (flat) biosensor used in a microfluidic system.

Three electrodes, leads and contact pads were fabricated on a piece of silicon wafer
(covered by a 200 nm silicon dioxide layer) using a photolithography method mentioned
in Chapter 3. Only the area of the working electrode was made nanoporous and modified
with catalysts and enzymes. A tiny drop of Ag/AgCl (AG-500, Conductive Compounds)
ink was added on the reference electrode area. These three electrodes form a planar
biosensor on the wafer (Figure 5.7a). The design of a microfluidic chip is similar to the
previous blood separation design and the detailed fabrication process is available in
Chapter 3. The microfluidic chip made of PDMS was cleaned in a 15 minutes UV Ozone treatment process. Right after this treatment, the PDMS layer was brought into
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contact with the wafer layer, and pressed with 10 N force for 2 hours to increase the
bonding strength and stored in a fridge (4°C) for testing (Figure 5.7b).

With the propulsion from a syrine pump (BS-8000, Braintree Scientific Inc.), DI water was
pumped through the microchannel at a constant flow rate (30 µL s-1) for a specific
duration. Then, the flow of DI water was stopped and standard glucose solution (2 mM)
was loaded into the system. The sensing chip was connected to a potentiostat to perform
chronoamperometric measurements. The comparison involves the nanoporous biosensor
and the conventional biosensor, so the steady state currents at 100 sec for both biosensors
were picked up and used to calculate the measured concentration. As shown in Figure 5.8,
the measured values gradually decreased for both biosensors, but the value of the
conventional biosensor deviates from the standard concentration faster compared to that
of the nanoporous biosensor. Therefore, it is inferable that the nanoporous structure
serves as a better platform to prevent enzyme leakage in a microfluidic system.
(a)

(b)
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Figure 5.7: (a) A nanoporous, thin film and planar electrode system fabricated on a
piece of silicon wafer. The diameter of the working electrode is 3 mm. (b) A
biosensor embedded in a microfluidic chip. The depth of the microchannel is 50 µm.
Control experiments were conducted using this configuration to show the
advantages of nanoporous working electrodes in the microfluidic system.
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Figure 5.8: The duration of DI water flowing vs. the measured concentrations.

The advantage of the nanoporous electrode is also demonstrated by its superior
performance after the enzyme and nafion are entrapped in electrodes. First, the nonporous
structure possesses a larger surface area and more active sites, which results in an
increase of steady-state Faraday current, compared with the flat electrode surface. Second,
immobilization methods based on chemical modification can change the MichaelisMenten constant of the enzymes because of the steric and conformational alterations [25].
Therefore, physical adsorption and entrapment is a better method to retain enzyme
activity. Third, nanoporous metals can enhance the electrochemical transduction of redox
enzymes. The continuity of metallic nanoscaled ligaments and nanoporous channels
contributes to good electrical conductivity of nanoporous metals. The catalyst and the
enzyme are well-dispersed and entrapped in the porous matrix, so that these form a
conducting network aiding charge transfer through the film. Therefore, the biosensor has
higher response to target analyte due to the high activity of electrocatalysis [26-27].
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5.4 Conclusions
We have successfully fabricated nanoporous structures directly on a planar thin film Au
electrode, and applied them to configure an enzymatic electrochemical biosensor.
Experimental results show that the layer of nanosized metallic ligaments and nanopores
complexes possess 60 times more active surface area than a flat layer, and can act as an
ideal platform for the immobilization of catalysts and enzymes, with enhanced charge
transport and bioelectrocatalytic properties, yielding high electrochemical responses. The
use of this sensor in the detection of glucose shows a wide linear range (up to 30 mM),
high sensitivity (0.50 µA mM-1 mm-2) and low interference. This work shows great
promise for designing on-chip electrochemical biosensors used in point-of-care
diagnostics.
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Chapter 6
6 A Robust Lab-on-a-CD System for High-throughput and
Automated Whole Blood Analysis
Based on the blood separation technique and the electrochemical detection method
introduced above, a Lab-on-a-CD prototype was built and its performance is evaluated in
this chapter. The detections of the concentrations of glucose, lactate and uric acid were
employed as examples to prove the robustness of the prototype.

6.1 Introduction
A massive inequality in health exists across the globe. Medical care in low resource areas
requires the development of a portable, low cost and effective monitoring and diagnostic
method [1-6]. In field blood tests and remote medical care are the best option to provide a
comprehensive treatment for patients. Blood tests are the most commonly-used
diagnostic methods currently because blood analysis provides definitive information
about patients’ medical conditions. Comprehensive blood analysis, including sample
collection, preparation and detection, is conducted using large-scale blood analyzers and
has not become fully point-of-care (POC) yet.

Lab-on-a-chip [7] technology provides an automatic, cost-effective and fast solution for a
wide variety of blood analyses. As a main branch of Lab-on-a-chip technology, the Labon-CD (compact disc) technique [8] is a promising and attractive option due to the
centrifugal force applied during the rotation of the disk. The centrifugal force is able to
drive flow from the center of the rotation to the edge of the centrifugal platform,
transporting samples and reagents from the inlet reservoirs to the metering, mixing,
reaction, detection and waste reservoirs.
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The Lab-on-a-CD platform possesses the potential to integrate all conventional blood
analysis steps into one continuous process. A large number of research groups have
engaged in the exploration of the Lab-on-a-CD system for blood analysis. So far, the
major achievement is performing blood separation on the centrifugal platform [9-13].
Sample manipulation, including valving [14], metering [15], and mixing [16], have also
been successfully demonstrated on the platform. However, these are only pre-process
steps for blood analysis, and their designs are delicate, requiring complicated fabrication
steps. Furthermore, quantitative detection of blood samples has not yet been integrated on
the centrifugal platform.

Since blood separation is prior to subsequent blood tests in clinical diagnosis [9, 12, 13],
our group has demonstrated the robustness of using 3D out-of-plane microvalves for
whole blood separation on a centrifugal platform [12]. The microfluidic cartridge was
composed of two reservoirs (inner and outer reservoirs), which were connected by the
out-of-plane microvalve. This design aims to reduce the complexity of the system by
eliminating the step of blood plasma transfer. The inner reservoir served as a sample
collection reservoir at the sample loading step, and turned into a detection reservoir at the
quantitative analysis step. The electrochemical system embedded in the inner reservoir
was pre-loaded with catalyst and enzyme, which risked being washed off under the high
speed of the blood flow. We designed and fabricated a type of nanoporous thin-film
working electrode to overcome this technical problem (Chapter 5). All the work is
dedicated to the developing a low-cost, portable system for multiple and parallel POC
blood analyses. In the following sections, the design and fabrication of the completed
Lab-on-a-CD system is elucidated in detail, while the performance of the system is
demonstrated and evaluated.
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6.2 Theory and Design of System
Based on its functions, the Lab-on-a-CD system can be divided into an upstream section
for whole blood separation and a downstream section for quantitative analysis. My design
employed the centrifugal force as the driving force for blood pumping and separation.
The centrifugal force of the Lab-on-a-CD system is ideal for separating blood cells from
plasma according to their density difference, because it shares the same mechanism as the
conventional bench-top blood separation approach using a large, high-speed centrifuge.
The microfluidic structure was created on a centrifugal platform, extending with its inner
and outer radial positions of 13 mm and 33 mm, respectively. While the centrifugal
platform rotated, blood cells moved outward to the outer reservoirs and plasma was
squeezed inward to the inner reservoirs. As the volume percentage of red blood cells in
blood (hematocrit) is less than 50% [17] and the volume ratio of the outer reservoir to the
inner reservoir is 1.5, the blood cells only accumulated in the outer reservoir. 3D Out-ofplane microvalves were employed to isolate the inner reservoirs and the outer reservoirs,
ensuring the purity of plasma in the inner reservoirs [12]. Obviously, the functions of the
micropumps and microvalves were realized on the CD platform at the same time without
integration of actuation and any auxiliary equipment, which greatly reduces the
complexity and the cost of the system. Afterwards, an electrochemical system with high
sensitivity and selectivity was placed in the inner reservoirs downstream to extract
biological information from the purified plasma. The contents of the plasma reacted with
enzymes and produced electroactive species, which were electrochemically oxidized or
reduced at metal electrodes. Under the potential provided from a meter, current was
generated from the electrons produced in redox. This current was calibrated to measure
the concentration of the constituents in whole blood. Without the disturbance from the
blood cells, the results from electrochemical detection will have a high accuracy.

Based on the spatial structure, the Lab-on-a-CD system can be exploded into three layers
(Figure 6.1). The top layer is a microfluidic cartridge, which was casted from a polymer
mold. Microfluidic channels, inlets and vents are arranged in this layer to connect the
microfluidic system to the macro-world. The middle layer serves as an insulating layer
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that covers the leads and exposes the surface areas of the electrodes and the contact pads.
Electrochemical biosensors for quantitative analysis and 3D out-of-plane valves are
designed on the bottom layer. The electrochemical biosensors were connected to a
potentiostat through the contact pads. In a test, a whole blood sample was loaded into one
of the sections through an inlet, and the blood plasma was obtained and retained in the
inner reservoir under the centrifugal force field. As it was electrically connected to the
biosensor, the potentiostat applied potential between a working electrode and a counter
electrode and acquired a relevant electrical signal, which can be used to calculate the
concentration of a specific analyte. Multiple sections can be arranged in one circular
platform, and each section can independently perform a test. These duplicate sections can
either measure different contents for the same blood sample, or detect the same
constituents for diverse blood samples. This is a continuous process, including sample
collection, preparation and detection, reducing the turn-around time and risk of human
errors in processing steps. This is also a miniaturized device, which reduces the
consumption of blood samples and reagents.

Figure 6.1: Exploded view of the configuration of one Lab-on-a-CD section. It is
comprised of a microfluidic layer, an insulating layer and a biosensing layer.
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6.3 Experimental
6.3.1 Materials and apparatus
D-(+)-glucose, glucose oxidase (GOx, Type X-S, 250 units/mg), uric acid, uricase (UOx),
sodium L-lactate (~98%), lactate oxidase (LOx, ≥ 20 U/g, Sigma), human serum (S22571ml), bovine serum albumin (BSA), iron (III) chloride, and potassium ferricyanide (III)
ascorbic acid, (100 - 250 U/mg), Nafion (5 wt. %), PDDA (20 wt % in water), glucose
assay kit, lactate assay kit, uric acid kit and benzyl alcohol (anhydrous, 99.8%) were
purchased from Sigma-Aldrich. Piranha solution was made using H2O2 (30%) and H2SO4
(conc) solution in 1:3 vol/vol ratio. The multi-wall carbon nanotubes (MWCNT) with
95% purity (purchased from US Research Nanomaterials, Inc) are cylindrical with a
diameter in the range 5 – 15 nm. All processing solutions were prepared with de-ionized
(DI) water from a Milli-Q system (Millipore, Bedford, MA) and all other chemicals were
of analytical grade. 20 mM phosphate buffer solutions (PBS) with 0.1 M KCl were
freshly prepared every week. Human serum samples were prepared by dissolving
lyophilized sera with 1 ml DI water. All chemicals were employed without further
purification. All electrochemical experiments in this experiment were performed on a
computer-controlled potentiostat (CHI1200a, CHI Instruments, Inc., USA). A UV-visible
spectrophotometer from Varian was employed to provide references of analytes’
concentrations in samples using the standard assay kits. A brushless servomotor with a
servo drive was employed to control the motion of the Lab-on-a-CD system.

6.3.2 Device fabrication
6.3.2.1 Fabrication of microfluidic cartridge
A microfluidc cartridge was designed using AutoCAD, and its layout was printed on a
piece of acetate sheet as a photomask using a high-resolution (2000DPI) printing service
from CAD/Art Service Inc.. A polymer mold was fabricated on a silicon wafer using a
standard

photolithography

technique.

The

microfluidic

cartridge

made

of

polydimethysiloxane (PDMS) was replicated from the polymer mold. A large number of
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PDMS microfluidic cartridges could be repeatedly replicated from one polymer mold.
The details of the fabrication steps are available in my previous publication [12].

As shown in Figure 6.2a, the microfluidic cartridge is comprised of eight parallel sections,
and each section is composed of a sample inlet, an inner (sampling and detection)
reservoir, an outer (blood cells) reservoir and a vent. The depth of the microfluidic
structure is 100 µm, and the volumes for the inner reservoir and outer reservoir are 6.5
µL and 9.5 µL, respectively. Since the PDMS layer is inversely bonded to the biosensing
layer, the out-of-plane microvalves were not directly fabricated on the PDMS
microfluidic channels. They were arranged on the biosensing layer, and would insert into
the microfluidic channels after assembly, serving as out-of-plane valves. (Figure 6.2c)

6.3.2.2 Fabrication of biosensors
The design for the biosensor is based on the electrochemical detection technique. The
planar electrochemical system contains a microfabricated Au working electrode, a
silver/silver chloride reference electrode and a Au counter electrode (Figure 6.2b).
Through an alloy/dealloy process, the working electrode was made to be nanoporous and
then was modified with four layers: a multi-wall carbon nanotubes (MWCNT) layer, a
catalyst layer (Prussian Blue), an enzyme layer and a semi-permeable layer (Nafion)
(from bottom to top). The detailed procedure is as follows:
(1) Defined the surface area of the electrode system on a silicon wafer (with a 1000 nm
thick silicon dioxide layer on top) using positive photoresist and deposited a 100 nm
thick Au layer over the patterned photoresist layer. Lifted off the photoresist, leaving
an area with coated Au to be used for the electrodes, the leads and the conductive
pads.
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(2) Defined the surface area of the working electrode using positive photoresist and
deposited a 500 nm thick Zn layer on top of the Au layer. Lifted off the unwanted Zn
area and formed the nanoporous structure on the working electrode (chapter 5).
(3) Defined the surface area of the reference electrode using positive photoresist and
deposited a 500 nm thick Ag layer on top of the Au layer. Lifted off the unwanted
Ag area and dipped the wafer sample into 50 mM FeCl3, forming a Ag/AgCl
standard reference electrode.
(4) Covered the leads with a layer of negative photoresist, only exposing the areas of the
electrodes and the conductive pads on the whole wafer.
(5) Physically deposited 10 µL of MWCNT (1 mg/ml) onto the surface of the working
electrode.
(6) Electrodeposited a PB layer as a catalyst layer, physically deposited bovine serum
albumin (BSA) and enzyme mixture as a biomarker layer, physically deposited 10%
Nafion solution as a semi-permeable layer. These layers were all overlaid on the
working electrode.

6.3.2.3 Device assembly
The microfluidic layer was washed with isopropanol and DI water, respectively. Next, it
was cleaned and hydrophilicly modified in a 15 minute UV - Ozone treatment process.
Right after this treatment, the microfluidic layer was placed on the silicon wafer layer, on
which the biosensing components and out-of-plane valves were arranged. Alignment
marks were designed and fabricated into both layers to assure alignment was accurate.
Subsequently, these two assembled layers were pressed together with a force of 10 N for
2 hours to increase the bonding strength. Finally, the Lab-on-a-CD system was
completely built up (Figure 6.2c), and stored in a fridge (4°C) for further testing.
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(a)

(b)

Inlet
Vent

Inner Reservoir
Outer Reservoir

(c)

Valve

Figure 6.2: Photo of components and assembled device. (a) a microfluidic cartridge
made of PDMS; (b) An array of electrochemical biosensors built on a Si wafer; (c)
assembly of the PDMS chip and the Si wafer.

6.3.3 Measurements
The Lab-on-a-CD panel was placed on a motor and commands were sent from a
graphical user interface to control the motion of the CD panel. The electrochemical
results were read by a portable potentiostat and fed into a personal computer.
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Human serum sample was formulated by dissolving lyophilized sera with 1 mL DI water,
and the concentrations of its analytes were measured based on a spectrophotometric
method using three standard test kits. Then serum samples with different concentrations
of glucose, uric acid and lactate were prepared by diluting with DI water or adding more
analytes. The spiked serum samples were directly loaded in some of the sections of the
system without the rotation of the CD panel, and the calibration data was obtained from
the potentiostat. Human whole blood was taken from healthy donors at the University
Hospital and stored in an anticoagulant (EDTA) treated vacutainer tube. Once the
calibration curve was drawn, whole blood samples were loaded into the unused sections
of the system, and the testing procedure is shown as follows (Figure 6.3):
(1) A 16 µL blood sample was transferred from the vacutainer tube to the inlet of the
cartridge using a syringe.
(2) The Lab-on-a-CD panel was rotated at 2000 rpm for 280 seconds.
(3) The Lab-on-a-CD panel stopped rotating and the leads of the potentiostat were
connected to the conductive pads on each section of the CD panel.
(4) Electrochemical measurements were carried out by applying potential from the
potentiostat.
(5) Current values vs. time were recorded in a computer through commercial software.
(6) The current values at 150 second were picked up and used to calculate the
concentrations of analytes.
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Figure 6.3: Schematics of the experimental steps. A blood sample was loaded into
the system at 0 rpm. The rotational speed was ramped from 0 rpm up to 2000 rpm
in the first 10 second. The speed was kept at 2000 rpm for 110 seconds, and then
slowly decreased to 0 rpm. Electrochemical measurements were conducted when the
circular platform was stationary.

6.4 Results and Discussion
6.4.1 Device characterization
Each Lab-on-a-CD panel can continuously accomplish sample collection, preparation
(separation) and detection. Figure 6.4 demonstrates the whole system setup. As shown in
the insert of Figure 6.4a, the blood sample filled the inner reservoirs and outer reservoirs,
and the biosensor was immersed in the sample. The electrochemical reaction will not start
until the potential was applied from the potentiostat. Once the panel started rotating, the
blood cells with higher density flowed outward to the outer reservoirs, the so called blood
cells reservoirs. Meanwhile, the plasma was squeezed inward to the inner reservoirs
(plasma reservoirs). When the panel stopped moving, the out-of-plane microvalves broke
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the flow in the microfluidic channels, isolating the separated blood cells and plasma
(Figure 6.4b).

Software

Motor
Controller

Potentiostat
CD Panel

Electrode
Leads
Motor

(a)

Plasma
Blood cells

(b)

Figure 6.4: Whole blood analysis using a Lab-on-a-CD system. (a) sample loading
and ready for rotation; (b) Rotation ceased and electrochemical signals measured.
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The device was first characterized by its bonding strength. For the rotational speed of
2000 rpm, the blood sample with a density of 1125 kg/m3 exerted approximately 25 kPa
to the interface of the outer reservoir’s perimeter. The higher the rotational speed, the
larger the pressure of blood flow would be. Without enough bonding strength, blood
leaked out of the system, resulting in a failed measurement. Two parameters used in the
fabrication process to control the bonding strength were the duration of UV-Ozone
treatment and the duration of diffusion bonding. Bonding force was optimized at 10 N,
avoiding the collapse of the microfluidic structure. At a rotational speed of 2000 rpm, 15
minutes UV-Ozone treatment and 2 hour diffusion bonding can protect the device from
leakage. Meanwhile, this bonding is not a permanent bonding, so the assembled layers
can be separated and cleaned for further experiments. For disposable cartridges,
permanent bonding can be applied by using longer UV-Ozone treatment and diffusion
bonding.

6.4.2 Quantitative measurement
Biodetection was carried out when the potential from a potentiostat was applied on these
electrodes. We designed this system as a universal system by electrochemically detecting
H2O2, generated by the analytes in their enzymatic reactions (Equation 6.1 – 6.3) [18-20].
The amount of H2O2, which is proportional to the concentration of the analyte, can
catalytically react with the Prussian white (PW) by oxidizing PW to PB and PB itself is,
in turn, electrochemically reduced back to PW under the applied potential on the surface
of the working electrode (Equation 6.4). For a demonstration of the universal property of
this system, three enzymes (GOx, UOx, and LOx) were immobilized on different
working electrodes to measure glucose, uric acid, and lactate, respectively.
β  D  glucose  O 2 GOx

 gluconolactone  H 2 O 2

(6.1)

UOx
uric acid  O 2  H 2 O 
 allantoin  CO 2  H 2 O 2

(6.2)

Ox
L - Lactate  O 2 L

 Pyruvate  H 2 O 2

(6.3)
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K 2 Fe 2 Fe 2 (CN) 6  2H 2 O 2  KFe 3 Fe 2 (CN) 6  K   2H 2 O  O 2

(6.4)

These three kinds of biosensors were first calibrated with spiked serum samples using
chronoamperometry. In the chronoamperometric measurement, constant potential (0 V vs
Ag/AgCl) was applied between the working electrode and the counter electrode to
measure the current due to the cathodic reduction of hydrogen peroxide aided by PB [21].
The current induced by electron transfer is called as the Faradic current and is
proportional to the concentration of the analyte. From Figures 6.5 – 6.7, we can see that a
large capacitive current is present at the beginning, and then Faradic current occurs and
decays as t-1/2 until it reaches a steady state. The relationship of the Faradic current and
analyte concentration can be described by the Cottrell equation (for planar electrodes)
[22].
i

nFAD1 / 2 0
C
(t )1 / 2

(6.5)

Where i is the Faradic current, n is the number of electrons, F is Faraday's constant, A is
the area of the electrode, t is the time, D and C0 are the diffusion coefficient and the initial
concentration of the target analyte, respectively. The steady state currents at 150 sec were
used to configure the calibration curves for the following analysis. The calibration curve
for glucose (Figure 6.5) shows linearity from 0 mM - 25 mM (R2 = 0.9929, n = 5), while
the linear ranges for uric acid (Figure 6.6) and lactate (Figure 6.7) are 0 mM - 5 mM (R2
= 0.9948, n = 5) and 0 mM – 1.5 mM (R2 = 0.9950, n = 5), respectively.

The normal level of glucose is from 3.5 to 5.3 mM in whole blood, and the conventional
detection limit is 0.5 mM with colorimetric methods and 1 mM with glucometers [23, 24].
The linear range of glucose provided by our Lab-on-a-CD system covers the entire range
of normal human blood glucose levels, with a competitive detection limit of 0.3 mM. The
Lab-on-a-CD system also shows competitive performance for the detection of uric acid
and lactate by covering the normal concentration ranges of uric acid (0.1 – 0.4 mM) and
lactate (0.7 – 1.7 mM).
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(a)

(b)

Figure 6.5:(a) Chronoamperograms of glucose with concentration from 0 mM to 25
mM. (b) Currents at 150th second plotted as a function of the concentration of
glucose.
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(a)

(b)

Figure 6.6:(a) Chronoamperograms of lactate with concentration from 0 mM to 1.5
mM. (b) Currents at 150th second plotted as a function of the concentration of
lactate.
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(a)

(b)

Figure 6.7:Chronoamperograms of uric acid with concentration from 0 mM to 5
mM. (b) Currents at 150th second plotted as a function of the concentration of uric
acid.
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By collecting the steady state currents of the separated plasma from unknown human
whole blood samples, we can calculate the concentration of the analyte using the
calibration curves obtained above. The quantitative results generated by the Lab-on-a-CD
system were compared with the reference values that were measured by
spectrophotometric method using standard test kits [25].

The measured value of glucose with the spectrophotometric method was 5.43 ± 0.08 mM,
whilst it was 5.21 ± 0.03 mM with the electrochemical method using the Lab-on-a-CD
system. Only a 4.2% difference exists between these two methods. The differences for
lactate and uric acid are 5.2% and 6.0%, respectively (Figure 6.8). This data proves the
practical utility of the proposed Lab-on-a-CD system. The robustness of the biosensor
was further proved by retaining approximately 85% of its initial sensitivity after a week
stored in PBS in a fridge (4°C).

Figure 6.8: The measured concentrations of glucose, lactate and uric acid with the
spectrophotometric method and the electrochemical method. The value differences
between these two methods are 4.2%, 5.2% and 6.0%, respectively.
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6.4.3 Discussion
The Lab-on-a-CD system here integrates three major steps of blood analysis into one
continuous process and provides quantitative information about human whole blood.

The nanoporous structure designed on the working electrode plays an important role in
the success of the Lab-on-a-CD system. On this centrifugal platform, a large number of
blood cells migrated at a high speed, and the resulting momentum was continuously
exerted on the enzyme and catalyst layer that were deposited on the surface of the
working electrode. Entrapped by the nanoporous working electrode, the deposited
materials avoided being washed away.

The measurement using this Lab-on-a-CD system possesses the accuracy to compete with
the conventional hospital measurement using sophisticated equipment carried out in large
central laboratories. As the disturbance from blood cells is eliminated, the accuracy of the
measured signal can be improved by about 10 - 15%, compared to the existing
commercial glucometers, which are based on electrochemical measurement with the unseparate whole blood. That is also the reason that hospitals still rely on the results using
separated plasma for diagnosis. The results from glucometers are only for monitoring
purposes or used as a reference. Furthermore, as this system integrates three separate
steps into one process, the possible errors due to human operation can be avoided. For
example, mislabelled samples, improper storage environment, etc. This system also
provides a visible detection process for patients, which can build their trust in the results.
Therefore, the system can give patients fast and straightforward results.

This is a universal platform for blood diagnostics. Besides glucose, uric acid and lactate,
we can extract more information from blood plasma by simply changing the enzyme.
Only if the enzymatic reaction produces H2O2, can the biosensor detect the concentration

146

of the analyte. This is also a high throughput measurement platform, on which more than
ten tests can be performed at a time. Normally, one piece of information from a patient’s
blood sample is not enough to conclude on his/her medical condition. Multiple tests are
necessary for a comprehensive diagnosis. With this system, the efficiency of diagnosis is
boosted, and the use of the blood sample is more efficient.

6.5 Conclusions
We designed a Lab-on-a-CD system to automate all of the manual steps of the traditional
blood analysis process. In our system, we achieve this automation by designing a
microfluidic system around electrochemical biosensors. Although only glucose, lactate
and uric acid were analyzed, the Lab-on-a-CD prototype is designed as a universal
platform to detect the concentration of analytes in whole blood based on the production
of hydrogen peroxide in enzymatic reactions.
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Chapter 7
7 Thesis Summary and Future Work
7.1 Summary
Without a complex integration of the actuating mechanism and associated marco-tomicro interface, a Lab-on-a-CD prototype has been successfully built and tested. It can
perform blood delivery, separation and detection in a continuous automated process. The
entire blood analysis procedure is completed on a compact Lab-on-a-CD platform
developed in this thesis. Whole blood samples were first collected and injected into the
system through sample inlets. Blood was delivered into different sections by the universal
centrifugal force due to the CD spinning. Blood cells and plasma were separated under
the centrifugal force field, and were isolated by the integrated out-of-plane microvalves.
Without being transferred to adjacent detection chambers, the extracted pure plasma was
analyzed by the electrochemical biosensors underneath. The working electrodes of the
electrochemical biosensors were made nanoporous in order to increase the electroactive
surface area and firmly confine the coated material. Quantitative information about
glucose, lactate and uric acid was obtained. The menu of detectable analytes can be
readily expanded to other biochemical reactions where hydrogen peroxide is produced in
enzymatic reactions. With modification of the biosensor configuration, the whole panel
of blood tests may be realized on such Lab-on-a-CD systems.

7.2 Thesis Contribution
The Lab-on-a-CD system developed here is an integrated platform demonstrating an
effective approach to process samples that are appropriate for point-of-care diagnostics,
especially for the use in low-resource settings. This design fills the gap between the
costly, non-instrumented sample pre-processing steps and the downstream analytedetection step.
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The present design overcomes some limitations in prior works such as blood separation,
complexity and the cost. This thesis provides a fully functional Lab-on-a-CD system that
integrates whole blood pumping and separation, and quantificational electrochemical
detections in parallel. A novel design of out-of-plane microvalves reduces the complexity
of the microfluidic networks and flow control, and therefore ensures high yield plasma
separation.

The factors that might affect the sensing sensitivity and the linear range of biosensors
were analyzed in detail. The results provide a guideline for the practical configuration of
biosensors according to diverse applications. Meanwhile, the nanoporous design of
working electrodes solves the problems for the embedding of the modified working
electrodes in microfluidic systems.

Each Lab-on-a-CD platform is a compact system, built by micro/nano fabrication
techniques, so it consumes less sample and reagents. Each mold can be repeatedly used
and the microfluidic cartridges are made of low-cost polymer material. Therefore, this
system is suitable for POC diagnostics, especially for areas with limited medical
resources.

The devices of the invention are suitable for the analysis of any liquid sample, typically a
biological sample such as whole blood. It is also useful with numerous other biological
samples, such as saliva, semen, sputum, urine, spinal fluid and the like, which need a
separation or concentration processing step.
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7.3 Future Work
Although a Lab-on-a-CD system for automated and high throughput blood analysis has
been built and verified, there is much room for innovation, adaptation, and cost reduction
before these technologies can impact health care in the developing world. For example,
the circular bio-platform will be designed with a receptacle or other coupling device
suitable for mounting on a vertical drive shaft provided by a rotor. It will be appreciated
that the bio-platform of the present invention may be adapted for use with all or most
types of rotors that are now available on the market. In addition, the portable potentiostat
used to perform electrochemical measurements has the potential to be minimized and
integrated on the bio-platform. The surface area of the electrodes can be reduced to the
micron scale, so each section will take up less area, resulting in more tests that can be
done on one panel. Furthermore, more detected functions should be explored on the Labon-a-CD system, such as immunoassay for the detection of acute myocardial infarction.
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